<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Ind Microbiol Biotechnol</journal-id><journal-id journal-id-type="iso-abbrev">J Ind Microbiol Biotechnol</journal-id><journal-id journal-id-type="publisher-id">jimb</journal-id><journal-title-group><journal-title>Journal of Industrial Microbiology &#x00026; Biotechnology</journal-title></journal-title-group><issn pub-type="ppub">1367-5435</issn><issn pub-type="epub">1476-5535</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8788784</article-id><article-id pub-id-type="pmid">34279640</article-id><article-id pub-id-type="doi">10.1093/jimb/kuab044</article-id><article-id pub-id-type="publisher-id">kuab044</article-id><article-categories><subj-group subj-group-type="heading"><subject>Natural Products</subject><subj-group subj-group-type="category-toc-heading"><subject>Review</subject></subj-group></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/SCI01150</subject><subject>AcademicSubjects/SCI00540</subject></subj-group></article-categories><title-group><article-title>Genome mining for drug discovery: progress at the front end</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Baltz</surname><given-names>Richard H</given-names></name><!--rbaltz923@gmail.com--><aff>
<institution>CognoGen Biotechnology Consulting</institution>, <addr-line>7757 Uliva Way, Sarasota, FL 34238</addr-line>, <country country="US">USA</country></aff><xref rid="cor1" ref-type="corresp"/></contrib></contrib-group><author-notes><corresp id="cor1">Correspondence should be addressed to: Richard H. Baltz. Phone: + 1-317-656-7601; E-mail: <email>rbaltz923@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><month>12</month><year>2021</year></pub-date><pub-date pub-type="epub" iso-8601-date="2021-07-19"><day>19</day><month>7</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>7</month><year>2021</year></pub-date><volume>48</volume><issue>9-10</issue><elocation-id>kuab044</elocation-id><history><date date-type="received"><day>22</day><month>5</month><year>2021</year></date><date date-type="accepted"><day>11</day><month>7</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2021. Published by Oxford University Press on behalf of Society of Industrial Microbiology and Biotechnology.</copyright-statement><copyright-year>2021</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="kuab044.pdf"/><abstract><title>Abstract</title><p>Microbial genome mining for drug discovery and development has been accelerating in recent years, driven by technical advancements in genome sequencing, bioinformatics, metabolomics/metabologenomics, and synthetic biology. Microbial genome mining is a multistep process that starts with the sequencing of microbes that encode multiple secondary metabolites and identifying new and novel secondary metabolite biosynthetic gene clusters (BGCs) to pursue. The initial steps in the process are critical for the overall success, and they encompass the most innovative new technologies to revitalize natural product discovery. As microbial genome mining has matured in recent years, unvalidated conjectures about what microbes to pursue, how to identify legitimate secondary metabolite BGCs, and how to sequence DNA to satisfactory levels of completion have been identified. The solutions to correct the misconceptions around these topics are beginning to be implemented.</p></abstract><kwd-group kwd-group-type="keywords"><kwd>Actinobacteria</kwd><kwd>Actinomycete</kwd><kwd>Combinatorial biosynthesis</kwd><kwd>Genome mining</kwd><kwd>Myxobacteria</kwd><kwd>Nonribosomal peptide synthetase</kwd><kwd>Polyketide synthase</kwd><kwd>
<italic toggle="yes">Streptomyces</italic>, Synthetic biology</kwd></kwd-group><counts><page-count count="11"/></counts></article-meta></front><body><def-list><title>Abbreviations used</title><def-item><term>A,</term><def><p>adenylation domain</p></def></def-item><def-item><term>ACP,</term><def><p>acyl carrier protein</p></def></def-item><def-item><term>BGC,</term><def><p>biosynthetic gene cluster</p></def></def-item><def-item><term>C,</term><def><p>condensation domain</p></def></def-item><def-item><term>CAT,</term><def><p>NRPS elongation module</p></def></def-item><def-item><term>CATTe,</term><def><p>NRPS elongation/termination module</p></def></def-item><def-item><term>E,</term><def><p>epimerase</p></def></def-item><def-item><term>FAAL,</term><def><p>fatty acyl-AMP ligase</p></def></def-item><def-item><term>MRSA,</term><def><p>methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic></p></def></def-item><def-item><term>NRP,</term><def><p>nonribosomal peptide</p></def></def-item><def-item><term>NRPS,</term><def><p>nonribosomal peptide synthetase</p></def></def-item><def-item><term>PCP,</term><def><p>peptidyl carrier protein</p></def></def-item><def-item><term>PK,</term><def><p>polyketide</p></def></def-item><def-item><term>PKS-I,</term><def><p>type I polyketide synthetase</p></def></def-item><def-item><term>T,</term><def><p>thiolation (PCP) domain</p></def></def-item><def-item><term>Te,</term><def><p>thioesterase domain</p></def></def-item></def-list><sec sec-type="intro" id="sec2"><title>Introduction</title><p>Natural products continue to be important sources for the discovery and development of antibiotics, immune modulators, and antitumor agents for human medicine, and other products for use in animal health and plant crop protection (Baltz, <xref rid="bib10" ref-type="bibr">2019</xref>; Demain, <xref rid="bib30" ref-type="bibr">2014</xref>; Katz &#x00026; Baltz, <xref rid="bib51" ref-type="bibr">2016</xref>; Newman &#x00026; Cragg, <xref rid="bib71" ref-type="bibr">2020</xref>). The concept of microbial genome mining to revitalize drug discovery emerged in the early 2000s from the observations that newly sequenced actinomycete genomes encode many more secondary metabolite biosynthetic gene clusters (BGCs) than predicted from known secondary metabolomes (Baltz, <xref rid="bib3" ref-type="bibr">2008</xref>; Bentley et al., <xref rid="bib13" ref-type="bibr">2002</xref>; Ikeda et al., <xref rid="bib47" ref-type="bibr">2003</xref>; Ohnishi et al., <xref rid="bib74" ref-type="bibr">2008</xref>; Oliynyk et al., <xref rid="bib75" ref-type="bibr">2007</xref>). In recent years, the discovery of new and novel natural products has been accelerating by advancements in the microbial genome mining processes (Bachmann et al., <xref rid="bib2" ref-type="bibr">2014</xref>; Baltz, <xref rid="bib6" ref-type="bibr">2017a</xref>, <xref rid="bib8" ref-type="bibr">2017c</xref>, <xref rid="bib10" ref-type="bibr">2019</xref>; Foulston, <xref rid="bib33" ref-type="bibr">2019</xref>; Kalkreuter et al., <xref rid="bib49" ref-type="bibr">2020</xref>; Mitousis et al., <xref rid="bib66" ref-type="bibr">2020</xref>; Musiol-Kroll et al., <xref rid="bib68" ref-type="bibr">2019</xref>). Genome mining also provides an ever-expanding set of genetic parts and devices for synthetic biology approaches to facilitate combinatorial biosynthesis of novel variants of biologically active secondary metabolites, such as antibiotics (Baltz, <xref rid="bib9" ref-type="bibr">2018</xref>, <xref rid="bib10" ref-type="bibr">2019</xref>, <xref rid="bib11" ref-type="bibr">2021</xref>; Katz et al., <xref rid="bib52" ref-type="bibr">2018</xref>; Whitford et al., <xref rid="bib94" ref-type="bibr">2021</xref>; Yuzawa et al., <xref rid="bib97" ref-type="bibr">2018</xref>). In this perspective, I focus on a few key advancements and opportunities at the front end of the genome mining discovery process and limit my discussions to bacteria, primarily actinomycetes. I also discuss three examples of applying evolutionary relationships within families of BGCs encoded by nonribosomal peptide synthetase (NRPS) and polyketide synthase (PKS-I) mechanisms to facilitate genome mining of structural variants of pharmacologically privileged chemical scaffolds.</p></sec><sec id="sec3"><title>The Genome Mining Process</title><p>The genome mining process involves the identification of new and novel secondary metabolite BGCs for product development. The process from genome sequence analysis to product launch can be described as a nine-step value chain (Baltz, <xref rid="bib10" ref-type="bibr">2019</xref>) as follows: (i) identify the most promising microbes and sequence their genomes; (ii) identify new and novel secondary metabolite BGCs and their products; (iii) develop fermentation processes to produce large quantities of targeted molecules; (iv) isolate and characterize molecules of interest; (v) determine biological activities of candidate molecules; (vi) optimize the pharmacological properties of promising molecules by medicinal chemistry and combinatorial biosynthesis; (vii) pursue clinical development of promising molecules; (viii) obtain regulatory approval for molecules that meet clinical success criteria; and (ix) market approved compounds. As with any drug discovery process, failure can occur at any step in the value chain. With microbial genome mining, it is critical to optimize the first two steps in the process to enable success in subsequent steps. Importantly, the first two steps present the largest opportunities for transformative innovation in natural product discovery. All subsequent steps in the process have been implemented successfully in the past, but can be further optimized by applying recent advancements in synthetic biology, metabolomics, metabolic engineering, and other technologies. The downstream steps of the genome mining process are beyond the scope of this perspective. Interested readers are referred to recent reviews on other technical advances relevant to bioinformatics, product expression, and strain engineering (Baltz, <xref rid="bib5" ref-type="bibr">2016</xref>; Blin et al., <xref rid="bib17" ref-type="bibr">2019</xref>; Kang &#x00026; Kim, <xref rid="bib50" ref-type="bibr">2021</xref>; Kautsar et al., <xref rid="bib54" ref-type="bibr">2021</xref>; Lee et al., <xref rid="bib58" ref-type="bibr">2020</xref>; Merwin et al., <xref rid="bib64" ref-type="bibr">2020</xref>; Navarro-Mu&#x000f1;oz et al., <xref rid="bib70" ref-type="bibr">2020</xref>; Nguyen et al., <xref rid="bib72" ref-type="bibr">2020</xref>; Palazzotto et al., <xref rid="bib77" ref-type="bibr">2019</xref>; Ren et al., <xref rid="bib78" ref-type="bibr">2020</xref>; Schorn et al., <xref rid="bib79" ref-type="bibr">2021</xref>; Sharma et al., <xref rid="bib80" ref-type="bibr">2020</xref>; Skinnider et al., <xref rid="bib82" ref-type="bibr">2020</xref>; Stahlecker et al., <xref rid="bib83" ref-type="bibr">2021</xref>; van der Heul et al., <xref rid="bib88" ref-type="bibr">2018</xref>; Wang et al., <xref rid="bib92" ref-type="bibr">2019</xref>; Whitford et al., <xref rid="bib94" ref-type="bibr">2021</xref>; Xu &#x00026; Wright, <xref rid="bib95" ref-type="bibr">2019</xref>).</p><p>Examples of mining individual actinomycete genomes have been successful in identifying new and novel secondary metabolite BGCs because they utilized finished-quality genomes (Aigle et al., <xref rid="bib1" ref-type="bibr">2014</xref>; Bentley et al., <xref rid="bib13" ref-type="bibr">2002</xref>; Challis, <xref rid="bib22" ref-type="bibr">2014</xref>; Ikeda et al., <xref rid="bib47" ref-type="bibr">2003</xref>; Ikeda et al., <xref rid="bib48" ref-type="bibr">2014</xref>; Iftime et al., <xref rid="bib46" ref-type="bibr">2016</xref>; Ohnishi et al., <xref rid="bib74" ref-type="bibr">2008</xref>; Oliynyk et al., <xref rid="bib75" ref-type="bibr">2007</xref>; Thibessard et al., <xref rid="bib86" ref-type="bibr">2015</xref>). Finished-quality genomes facilitated the proper assembly of NRPS and PKS-I genes encoding multimodular multienzymes. In spite of these successful examples, most actinomycete genome sequences currently available in public databases are in draft form. Draft-quality genome sequences are sufficient for the correct assembly of many small, nonrepetitive secondary metabolite BGCs (e.g. RiPPs, terpenes, aminoglycosides, and type II polyketides) but not for large BGCs encoding new and novel secondary metabolites biosynthesized by NRPS of PKS-I mechanisms. NRPS and PKS-I BGCs are typically misassembled in draft genomes (Baltz <xref rid="bib7" ref-type="bibr">2017b</xref>, <xref rid="bib8" ref-type="bibr">2017c</xref>, <xref rid="bib10" ref-type="bibr">2019</xref>; Goldstein et al., <xref rid="bib35" ref-type="bibr">2019</xref>; Klassen &#x00026; Currie, <xref rid="bib55" ref-type="bibr">2012</xref>). For example, the daptomycin (NRPS) and spinosad (PKS-I) BGCs have been cloned in BAC and cosmid vectors, respectively, and sequenced to finished quality (Miao et al., <xref rid="bib65" ref-type="bibr">2005</xref>; Waldron et al., <xref rid="bib91" ref-type="bibr">2001</xref>). Two draft genome sequences of highly related <italic toggle="yes">Streptomyces roseosporus</italic> strains, both producers of daptomycin, were sequenced to draft quality by the Broad Institute, and both had NRPS assembly errors. The worst of the two, the commercial daptomycin producer, had one of the three NRPS subunits (<italic toggle="yes">dptA</italic>) correctly assembled, but two partial segments of <italic toggle="yes">dptBC</italic> were located on different contigs, each fused to heterologous NRPS fragments, and <italic toggle="yes">dptD</italic> was located on two different contigs, one of which was fused to a heterologous NRPS sequence (Baltz, <xref rid="bib7" ref-type="bibr">2017b</xref>). The spinosad BGC has five contiguous PKS-I genes, encoding SpnABCDE (Waldron et al., <xref rid="bib91" ref-type="bibr">2001</xref>). The draft genome sequence of <italic toggle="yes">Saccharopolyspora spinosa</italic>, the spinosad producer, has <italic toggle="yes">spnA</italic> assembled correctly, <italic toggle="yes">spnB</italic> is truncated, <italic toggle="yes">spnC</italic> is missing, <italic toggle="yes">spnD</italic> is split into two fragments on different contigs, one fused to a heterologous NRPS fragment, and the other fused to two heterologous NRPS fragments, and <italic toggle="yes">spnE</italic> is split into two fragments located on two different contigs (Baltz, <xref rid="bib7" ref-type="bibr">2017b</xref>). Furthermore, analysis of NRPS, PKS-I, and mixed NRPS/PKS-I annotated BGC sizes from other actinomycetes by antiSMASH indicated that the average actual BGC sizes from finished genomes are greater than twice as large as the predicted average BGC sizes from draft genomes, supporting the interpretation that many of the latter represent fragmented and misassembled &#x0201c;BGCs&#x0201d; (Baltz, <xref rid="bib7" ref-type="bibr">2017b</xref>). Since approximately 60% of important natural products or their derivatives for human medicine, animal health, and plant crop protection are of NRPS/PKS-I biosynthetic origins (Table S1), it is important to have finished-quality genomic sequences.</p><p>Successful genome mining for drug discovery requires having a robust front-end process of obtaining finished-quality genome sequences from the most gifted microbes that encode multiple secondary metabolite BGCs (Baltz, <xref rid="bib6" ref-type="bibr">2017a</xref>); rapid bioinformatic dereplication of known BGCs; avoidance of unvalidated hypothetical BGCs (Baltz <xref rid="bib8" ref-type="bibr">2017c</xref>, <xref rid="bib10" ref-type="bibr">2019</xref>); and identification of new and novel BGCs, supported by recent advances in metabolomic analyses (Doroghazi et al., <xref rid="bib31" ref-type="bibr">2014</xref>; Goering et al., <xref rid="bib34" ref-type="bibr">2016</xref>; Schorn et al., <xref rid="bib79" ref-type="bibr">2021</xref>). These guiding principles are imbedded in the first two steps in the value chain. Having a robust front-end of the drug discovery process is critical for the development of an overall process that consistently generates new product launches to meet important medical and agricultural needs.</p></sec><sec id="sec4"><title>DNA sequencing technology</title><p>The short-read massively parallel DNA sequencing paradigm using Illumina technology has been largely responsible for the rapid accumulation of draft genome assemblies publically available at the National Center for Biotechnology Information (nih.gov) (NCBI). This has been associated with the concept of &#x0201c;high-quality draft genomes&#x0201d; that can be generated very inexpensively. This high-quality notion is adequate for surveying large numbers of genomes for the presence or absence of normal-size genes (e.g. genes involved in primary metabolism or antibiotic resistance). It is not adequate for very large genes encoding repetitive functional domains such as NRPS or PKS-I genes.</p><p>Recently, significant advances have been made in long-read DNA sequencing methods developed by Pacific Biosciences (PacBio) and Oxford Nanopore Technologies (MinION). These methods can be coupled with Illumina short-read sequencing to obtain finished-quality sequences of very large genomes from microorganisms gifted for natural product biosynthesis, and which encode multiple BGCs that employ NRPS/PKS-I biosynthetic mechanisms (Gren et al., <xref rid="bib40" ref-type="bibr">2020</xref>; Gomez-Escribano et al., <xref rid="bib36" ref-type="bibr">2016</xref>; Gomez-Escribano et al., <xref rid="bib38" ref-type="bibr">2021</xref>; Gomez-Escribano et al., <xref rid="bib37" ref-type="bibr">2016</xref>; Goldstein et al., <xref rid="bib35" ref-type="bibr">2019</xref>; Guo et al., <xref rid="bib41" ref-type="bibr">2020</xref>; Heinsch et al., <xref rid="bib44" ref-type="bibr">2019</xref>; Kono &#x00026; Arakawa <xref rid="bib56" ref-type="bibr">2019</xref>; Lu et al., <xref rid="bib60" ref-type="bibr">2016</xref>; Na&#x000f4;m&#x000e9; et al., <xref rid="bib69" ref-type="bibr">2018</xref>; Nindita et al., <xref rid="bib73" ref-type="bibr">2019</xref>; Tian et al., <xref rid="bib87" ref-type="bibr">2015</xref>). These advances bode well for obtaining finished-quality genome sequences from many additional gifted microbes.</p></sec><sec id="sec5"><title>Rationale for sequencing gifted microbes that produce known secondary metabolites</title><p>One of the important aspects of natural product discovery in the pre-genomic era that led to the demise of previously successful programs in the pharmaceutical industry was the problem of rediscovery of known compounds (Katz &#x00026; Baltz, <xref rid="bib51" ref-type="bibr">2016</xref>). This was a major contributor to diminishing returns on investment that were not sustainable. An important advantage of microbial genome mining is the ability to focus on compounds predicted to be truly novel, and on derivatives of highly active molecules, based initially on bioinformatic analysis alone (Bachmann et al., <xref rid="bib2" ref-type="bibr">2014</xref>; Baltz, <xref rid="bib10" ref-type="bibr">2019</xref>, <xref rid="bib11" ref-type="bibr">2021</xref>). To accomplish this efficiently, it is important to have publicly available sequences from microbes that produce known compounds to serve as an open resource for rapid bioinformatic dereplication of known BGCs. In addition, such a database can serve as a source for mining other new and novel BGCs encoded by the reference genomes, and to support ongoing studies on the evolution and ecology of BGCs that can be applied to synthetic biology and combinatorial biosynthesis approaches to drug discovery (Baltz, <xref rid="bib9" ref-type="bibr">2018</xref>, <xref rid="bib11" ref-type="bibr">2021</xref>; Chevrette &#x00026; Currie, <xref rid="bib23" ref-type="bibr">2019</xref>; Chevrette et al., <xref rid="bib24" ref-type="bibr">2019</xref>; Chevrette et al., <xref rid="bib25" ref-type="bibr">2020</xref>; Culp et al., <xref rid="bib27" ref-type="bibr">2020</xref>; van Bergeijk et al., <xref rid="bib89" ref-type="bibr">2020</xref>; Waglechner et al., <xref rid="bib90" ref-type="bibr">2019</xref>).</p></sec><sec id="sec6"><title>Status of sequencing important secondary metabolite producing microbes</title><p>The question of which microbes encode the largest numbers of druglike natural products has been addressed recently (Baltz, <xref rid="bib6" ref-type="bibr">2017a</xref>, <xref rid="bib10" ref-type="bibr">2019</xref>). The most gifted microbes are those with large genomes, including many filamentous actinomycetes (dominated by <italic toggle="yes">Streptomyces</italic> species), and myxobacteria. Others include <italic toggle="yes">Burkholderia, Paenibacillus</italic>, and some species of Cyanobacteria. Those with small genomes, including <italic toggle="yes">Archaea</italic> and many unculturable bacteria, are the least gifted (Baltz, <xref rid="bib6" ref-type="bibr">2017a</xref>).</p><p>Important questions to address are the following: (i) how many finished genomes from gifted microbes are currently available in public databases to support bioinformatic dereplication and drug discovery by genome mining? and (ii) have we made significant progress in the expansion of finished genomes publically available in recent years?</p><sec id="sec6-1"><title>Publically available genome sequences</title><p>In July of 2020, there were 241,900 bacterial genome sequences available at NCBI (Table&#x000a0;<xref rid="tbl1" ref-type="table">1</xref>). Of these, 7.2% were of finished quality. Only 10% of the genome sequences were from Actinobacteria. From a drug discovery perspective, the most important Actinobacteria fall within the filamentous actinomycete genera, including <italic toggle="yes">Streptomyces, Micromonospora, Amycolatopsis, Actinoplanes, Saccharopolyspora</italic>, and others (Baltz, <xref rid="bib6" ref-type="bibr">2017a</xref>, <xref rid="bib8" ref-type="bibr">2017c</xref>; Katz &#x00026; Baltz, <xref rid="bib51" ref-type="bibr">2016</xref>). Table&#x000a0;<xref rid="tbl1" ref-type="table">1</xref> shows the numbers of filamentous actinomycete genome sequences for 14 genera that produce important secondary metabolites, ranging from 1,864 for <italic toggle="yes">Streptomyces</italic> to 1 for <italic toggle="yes">Streptoalloteichus</italic>, a tobramycin producer. The total filamentous actinomycete genome sequences (2,264) account for 0.98% of total bacterial sequences, whereas the pathogenic <italic toggle="yes">Mycobacterium</italic> sp. alone account for 7,497 of the Actinobacteria sequences. The Gamma Proteobacteria account for 122,764 sequences or 50.7% of the total. These are dominated by human pathogens, such as <italic toggle="yes">Escherichia coli, Pseudomonas</italic> sp., and <italic toggle="yes">Burkholderia</italic> sp. In contrast, within the Delta/Epsilon Proteobacteria, the Myxobacteria comprise only 287 sequences or 0.12% of the total. The Firmicutes account for 62,950 sequences (26% of total), and these are dominated by human pathogens, such as <italic toggle="yes">Staphylococcus</italic> and <italic toggle="yes">Streptococcus</italic> species. Thus, the bacterial genome sequences available in NCBI are heavily skewed in favor of human pathogens (approximately 75%) and underrepresented by genomes from filamentous actinomycetes and myxobacteria (approximately 1.1%), the highly gifted producers of antibiotics used to treat pathogens (Baltz, <xref rid="bib6" ref-type="bibr">2017a</xref>). Furthermore, just over 10% of filamentous actinomycete and myxobacterial genomes are of finished quality, so the approximately 90% of draft-quality genomes, mostly assembled by short-read Illumina technology, are not suitable to identify novel secondary metabolite BGCs that employ NRPS or PKS-I biosynthetic mechanisms, because of misassembly issues (Baltz, <xref rid="bib7" ref-type="bibr">2017b</xref>, <xref rid="bib9" ref-type="bibr">2018</xref>, <xref rid="bib10" ref-type="bibr">2019</xref>; Klassen &#x00026; Currie, <xref rid="bib55" ref-type="bibr">2012</xref>, Goldstein et al. <xref rid="bib35" ref-type="bibr">2019</xref>). Finishing many existing draft genomes, and increasing the numbers of finished genomes of gifted secondary metabolite producers available in NCBI has the potential to accelerate successful genome mining and combinatorial biosynthesis for drug discovery in the coming years.</p><table-wrap position="float" id="tbl1"><label>Table 1.</label><caption><p>Bacterial Genome Sequences Available at NCBI Genome<sup><xref rid="tb1fn1" ref-type="table-fn">a</xref></sup></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Microbial group</th><th align="center" rowspan="1" colspan="1">Genome assemblies</th><th align="center" rowspan="1" colspan="1">% of total</th><th align="center" rowspan="1" colspan="1">Finished assemblies</th><th align="center" rowspan="1" colspan="1">% Finished</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Bacteria</td><td rowspan="1" colspan="1">241,900</td><td rowspan="1" colspan="1">100</td><td rowspan="1" colspan="1">17,449</td><td rowspan="1" colspan="1">7.2</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Proteobacteria</td><td rowspan="1" colspan="1">122,764</td><td rowspan="1" colspan="1">50.7</td><td rowspan="1" colspan="1">9,880</td><td rowspan="1" colspan="1">8.0</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;Gamma</td><td rowspan="1" colspan="1">86,505</td><td rowspan="1" colspan="1">35.8</td><td rowspan="1" colspan="1">6,354</td><td rowspan="1" colspan="1">7.3</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Escherichia coli</italic></td><td rowspan="1" colspan="1">22,420</td><td rowspan="1" colspan="1">9.3</td><td rowspan="1" colspan="1">1,091</td><td rowspan="1" colspan="1">4.9</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Pseudomonas</italic> sp.</td><td rowspan="1" colspan="1">10,321</td><td rowspan="1" colspan="1">4.3</td><td rowspan="1" colspan="1">610</td><td rowspan="1" colspan="1">5.9</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Pseudomonas aeruginosa</italic></td><td rowspan="1" colspan="1">5,126</td><td rowspan="1" colspan="1">2.1</td><td rowspan="1" colspan="1">226</td><td rowspan="1" colspan="1">4.4</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Burkholderia</italic> sp.</td><td rowspan="1" colspan="1">3,258</td><td rowspan="1" colspan="1">1.3</td><td rowspan="1" colspan="1">281</td><td rowspan="1" colspan="1">8.6</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;Delta/epsilon</td><td rowspan="1" colspan="1">1,960</td><td rowspan="1" colspan="1">0.8</td><td rowspan="1" colspan="1">106</td><td rowspan="1" colspan="1">5.4</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Myxobacteria</td><td rowspan="1" colspan="1">287</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">11.5</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Firmacutes</td><td rowspan="1" colspan="1">62,950</td><td rowspan="1" colspan="1">26.0</td><td rowspan="1" colspan="1">3,971</td><td rowspan="1" colspan="1">6.3</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;<italic toggle="yes">Staphylococcus</italic></td><td rowspan="1" colspan="1">14,259</td><td rowspan="1" colspan="1">5.9</td><td rowspan="1" colspan="1">715</td><td rowspan="1" colspan="1">5.0</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;<italic toggle="yes">Streptococcus</italic></td><td rowspan="1" colspan="1">15,594</td><td rowspan="1" colspan="1">6.4</td><td rowspan="1" colspan="1">695</td><td rowspan="1" colspan="1">4.5</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Actinobacteria</td><td rowspan="1" colspan="1">23,106</td><td rowspan="1" colspan="1">9.6</td><td rowspan="1" colspan="1">1,715</td><td rowspan="1" colspan="1">7.4</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;<italic toggle="yes">Mycobacterium</italic></td><td rowspan="1" colspan="1">7,497</td><td rowspan="1" colspan="1">3.1</td><td rowspan="1" colspan="1">229</td><td rowspan="1" colspan="1">3.1</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Mycobacterium tuberculosis</italic></td><td rowspan="1" colspan="1">6,719</td><td rowspan="1" colspan="1">2.8</td><td rowspan="1" colspan="1">195</td><td rowspan="1" colspan="1">2.9</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;<italic toggle="yes">Nocardia</italic></td><td rowspan="1" colspan="1">190</td><td rowspan="1" colspan="1">0.08</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">10.0</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;Filamentous actinomycetes</td><td rowspan="1" colspan="1">2,364</td><td rowspan="1" colspan="1">0.98</td><td rowspan="1" colspan="1">248</td><td rowspan="1" colspan="1">10.5</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Streptomyces</italic></td><td rowspan="1" colspan="1">1,864</td><td rowspan="1" colspan="1">0.77</td><td rowspan="1" colspan="1">210</td><td rowspan="1" colspan="1">11.3</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Micromonospora</italic></td><td rowspan="1" colspan="1">161</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">4.3</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Amycolatopsis</italic></td><td rowspan="1" colspan="1">103</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">11.7</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Salinispora</italic></td><td rowspan="1" colspan="1">98</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2.0</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Nonomuraea</italic></td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">0.01</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">6.3</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Actinoplanes</italic></td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">0.01</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">28.6</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Saccharopolyspora</italic></td><td rowspan="1" colspan="1">25</td><td rowspan="1" colspan="1">0.01</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">8.0</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Saccharomonospora</italic></td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">0.008</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">10.5</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Saccharothrix</italic></td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">0.006</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">14.3</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Streptosporangium</italic></td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">12.5</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Lechevalieria</italic></td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Dactylosporangium</italic></td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0.0008</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Planobispora</italic></td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.0004</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;<italic toggle="yes">Streptoalloteichus</italic></td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.0004</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td></tr></tbody></table><table-wrap-foot><fn id="tb1fn1"><p>
<sup>a</sup>Data assembled in July, 2020.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec6-2"><title>Expansion of publically available microbial genome sequences</title><p>On August 16, 2016, 71,863 bacterial genome sequences were available in NCBI, of which 7.7% were finished (Baltz, <xref rid="bib8" ref-type="bibr">2017c</xref>) (Table&#x000a0;<xref rid="tbl2" ref-type="table">2</xref>). Therefore, total bacterial genome sequences have expanded 3.37-fold in about 4 years. <italic toggle="yes">E. coli</italic> genomes expanded 4.76-fold, from 4,706 to 22,420 in that timeframe, whereas myxobacterial sequences expanded from 41 to 287 (7.0-fold), and <italic toggle="yes">Streptomyces</italic> sequences expanded from 752 to 1,864 (2.48-fold). Somewhat discouragingly, the total numbers of finished myxobacterial and <italic toggle="yes">Streptomyces</italic> sequences have only expanded from 19 to 33, and 51 to 210, respectively. This defines a clear opportunity for future improvements in populating public databases with finished-quality sequences from gifted microbes to support drug discovery.</p><table-wrap position="float" id="tbl2"><label>Table 2.</label><caption><p>Increase in Bacterial Genome Sequences from 2016 to 2020</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Microbial group</th><th align="center" rowspan="1" colspan="1">Genome assemblies 2016<sup><xref rid="tb2fn1" ref-type="table-fn">a</xref></sup> (% finished)</th><th align="center" rowspan="1" colspan="1">% of total 2016<sup><xref rid="tb2fn1" ref-type="table-fn">a</xref></sup></th><th align="center" rowspan="1" colspan="1">Genome assemblies 2020<sup><xref rid="tb2fn2" ref-type="table-fn">b</xref></sup> (% finished)</th><th align="center" rowspan="1" colspan="1">% Of total 2020<sup><xref rid="tb2fn2" ref-type="table-fn">b</xref></sup></th><th align="center" rowspan="1" colspan="1">Genome assembly ratio (2020/2016)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Bacteria</bold>
</td><td rowspan="1" colspan="1">71,863 (NR<sup><xref rid="tb2fn3" ref-type="table-fn">c</xref></sup>)</td><td rowspan="1" colspan="1">100</td><td rowspan="1" colspan="1">241,900 (7.2)</td><td rowspan="1" colspan="1">100</td><td rowspan="1" colspan="1">3.37</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<bold>Proteobacteria</bold></td><td rowspan="1" colspan="1">33,627 (8.5)</td><td rowspan="1" colspan="1">46.8</td><td rowspan="1" colspan="1">122,764 (8.0)</td><td rowspan="1" colspan="1">50.7</td><td rowspan="1" colspan="1">3.65</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;<italic toggle="yes">Escherichia coli</italic></td><td rowspan="1" colspan="1">4,706 (4.1)</td><td rowspan="1" colspan="1">6.5</td><td rowspan="1" colspan="1">22,420 (4.9)</td><td rowspan="1" colspan="1">9.3</td><td rowspan="1" colspan="1">4.76</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;<italic toggle="yes">Pseudomonas</italic> sp.</td><td rowspan="1" colspan="1">2,625 (6.4)</td><td rowspan="1" colspan="1">3.7</td><td rowspan="1" colspan="1">10,321 (5.9)</td><td rowspan="1" colspan="1">4.3</td><td rowspan="1" colspan="1">3.93</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;<italic toggle="yes">Burkholderia</italic> sp.</td><td rowspan="1" colspan="1">1,210 (10.4)</td><td rowspan="1" colspan="1">1.7</td><td rowspan="1" colspan="1">3,258 (8.6)</td><td rowspan="1" colspan="1">1.3</td><td rowspan="1" colspan="1">2.69</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;Myxobacteria</td><td rowspan="1" colspan="1">41 (46.3)</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">287 (11.5)</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">7.00</td></tr><tr><td rowspan="1" colspan="1">
<bold>Firmacutes</bold>
</td><td align="center" rowspan="1" colspan="1">NR</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">62,950 (6.3)</td><td rowspan="1" colspan="1">26.0</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">
<bold>Actinobacteria</bold>
</td><td rowspan="1" colspan="1">7.863 (7.7)</td><td rowspan="1" colspan="1">10.9</td><td rowspan="1" colspan="1">23,106 (7.4)</td><td rowspan="1" colspan="1">9.6</td><td rowspan="1" colspan="1">2.94</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Mycobacterium</italic> sp.</td><td rowspan="1" colspan="1">4,527 (3.4)</td><td rowspan="1" colspan="1">6.3</td><td rowspan="1" colspan="1">7,497 (3.1)</td><td rowspan="1" colspan="1">3.1</td><td rowspan="1" colspan="1">1.66</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Nocardia</italic> sp.</td><td rowspan="1" colspan="1">103 (4.9)</td><td rowspan="1" colspan="1">0.14</td><td rowspan="1" colspan="1">190 (10.0)</td><td rowspan="1" colspan="1">0.08</td><td rowspan="1" colspan="1">1.84</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Streptomyces</italic></td><td rowspan="1" colspan="1">752 (6.8)</td><td rowspan="1" colspan="1">1.05</td><td rowspan="1" colspan="1">1,864 (11.3)</td><td rowspan="1" colspan="1">0.77</td><td rowspan="1" colspan="1">2.48</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Micromonospora</italic></td><td rowspan="1" colspan="1">21 (9.5)</td><td rowspan="1" colspan="1">0.03</td><td rowspan="1" colspan="1">161 (4.3)</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">7.67</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Amycolatopsis</italic></td><td rowspan="1" colspan="1">35 (25.7)</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">103 (11.7)</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">2.94</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Salinispora</italic></td><td align="center" rowspan="1" colspan="1">NR</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">98 (2.0)</td><td rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Nonomuraea</italic></td><td align="center" rowspan="1" colspan="1">NR</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">32 (6.3)</td><td rowspan="1" colspan="1">0.01</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Actinoplanes</italic></td><td rowspan="1" colspan="1">12 (33.3)</td><td rowspan="1" colspan="1">0.02</td><td rowspan="1" colspan="1">28 (28.6)</td><td rowspan="1" colspan="1">0.01</td><td rowspan="1" colspan="1">2.33</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Saccharopolyspora</italic></td><td rowspan="1" colspan="1">7 (14.3)</td><td rowspan="1" colspan="1">0.01</td><td rowspan="1" colspan="1">25 (8.0)</td><td rowspan="1" colspan="1">0.01</td><td rowspan="1" colspan="1">3.57</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Saccharomonospora</italic></td><td align="center" rowspan="1" colspan="1">NR</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">19 (10.7)</td><td rowspan="1" colspan="1">0.008</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Saccharothrix</italic></td><td align="center" rowspan="1" colspan="1">NR</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">14 (14.3)</td><td rowspan="1" colspan="1">0.006</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Streptosporangium</italic></td><td rowspan="1" colspan="1">3 (33.3)</td><td rowspan="1" colspan="1">0.004</td><td rowspan="1" colspan="1">8 (12.5)</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1">2.67</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Lechaveleria</italic></td><td align="center" rowspan="1" colspan="1">NR</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">8 (0)</td><td rowspan="1" colspan="1">0.003</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Dactylosporangium</italic></td><td rowspan="1" colspan="1">2 (0)</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1">2 (0)</td><td rowspan="1" colspan="1">0.0008</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Planobispora</italic></td><td align="center" rowspan="1" colspan="1">NR</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">1 (0)</td><td rowspan="1" colspan="1">0.0004</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Streptoalloteichus</italic></td><td align="center" rowspan="1" colspan="1">NR</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">1 (0)</td><td rowspan="1" colspan="1">0.0004</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr></tbody></table><table-wrap-foot><fn id="tb2fn1"><p>
<sup>a</sup>Data assembled from NCBI in August, 2016 (from Baltz, <xref rid="bib8" ref-type="bibr">2017c</xref>).</p></fn><fn id="tb2fn2"><p>
<sup>b</sup>Data assembled from NCBI in July, 2020.</p></fn><fn id="tb2fn3"><p>
<sup>c</sup>NR, not reported.</p></fn></table-wrap-foot></table-wrap><p>It is important to have finished-quality genome sequences from strains that produce known secondary metabolites to provide a baseline for bioinformatic dereplication to accelerate the discovery of new and novel secondary metabolites (Baltz, <xref rid="bib8" ref-type="bibr">2017c</xref>, <xref rid="bib10" ref-type="bibr">2019</xref>). They help support the important bioinformatic tools of antiSMASH, <italic toggle="yes">m</italic>inimal <italic toggle="yes">i</italic>nformation about a <italic toggle="yes">bi</italic>osynthetic <italic toggle="yes">g</italic>ene cluster (MIBiG), and IMG-ABC discussed below. As a starting point, the genome sequencing status of actinomycetes that produce 100 important antibiotics and other secondary metabolites was assembled in mid-2016 (Baltz, <xref rid="bib8" ref-type="bibr">2017c</xref>). The 100 compounds were produced by 94 actinomycetes, of which 56% had been sequenced, 28% to finished quality. The list was expanded to 142 secondary metabolites in July of 2020, and MIBiG status of the BGCs was included (Table S1). In some cases, more than one producing organism is included in Table S1 for various reasons. Some strains produce more than one of the 142 secondary metabolites (e.g. <italic toggle="yes">S. roseosporus</italic> produces daptomycin, arylomycin, napsamycin, and stenothricin, the latter three identified by genome mining coupled with MS/MS-based networking and peptidogenomics) (Liu et al., <xref rid="bib59" ref-type="bibr">2014</xref>). Genome sequences are available for producers of 98 of the compounds (69%), of which 53 have been finished (37.3%) (Table S2). 109 of the BGCs are available in MIBiG (79.6%), although MIBiG entries are not always matched with the original producers, or with producers with finished genomes. Also, 36 of the secondary metabolites in MIBiG are from sequenced BGCs not associated with the draft or finished genome sequences.</p><p>Much progress has been made in the last 4 years, but much more work can be done to provide finished genomes for the producers of important secondary metabolites, as exemplified in Table S1, to help provide a more robust open-access dataset for future genome mining efforts. The list of 142 important secondary metabolites produced by actinomycetes is a starting point, and should be expanded to encompass a more complete list of genomes to sequence to finished quality, and include a broader phylogenetic exposure to gifted microbes. It is noteworthy that 58% of the original 100 BGCs and 66.4% of the expanded list of 142 BGCs are of NRPS/PKS-I biosynthetic origins, further emphasizing the need to obtain finished-quality genomes to effectively mine these important BGCs that are routinely misassembled in draft genomes (Baltz <xref rid="bib7" ref-type="bibr">2017b</xref>, <xref rid="bib10" ref-type="bibr">2019</xref>; Goldstein et al., <xref rid="bib35" ref-type="bibr">2019</xref>; Klassen &#x00026; Currie, <xref rid="bib55" ref-type="bibr">2012</xref>).</p></sec></sec><sec id="sec7"><title>Bioinformatic analyses of secondary metabolite BGCs</title><sec id="sec7-1"><title>antiSMASH</title><p>antiSMASH was developed as a stand-alone bioinformatics tool to survey whole genome sequences for the presence of secondary metabolite BGCs. The first version was introduced in 2011 (Medema et al., <xref rid="bib62" ref-type="bibr">2011</xref>), followed by five upgrades to the present antiSMASH 6.0 (Blin et al., <xref rid="bib14" ref-type="bibr">2013</xref>, <xref rid="bib15" ref-type="bibr">2017</xref>, <xref rid="bib18" ref-type="bibr">2019</xref>, <xref rid="bib21" ref-type="bibr">2021</xref>; Weber et al., <xref rid="bib93" ref-type="bibr">2015</xref>). This extraordinary tool is very easy to use and is supported by the antiSMASH database (Blin et al., <xref rid="bib16" ref-type="bibr">2017</xref>, <xref rid="bib19" ref-type="bibr">2019</xref>, <xref rid="bib20" ref-type="bibr">2020</xref>). From a drug discovery perspective, antiSMASH 5.0 is very fast, and it can assign 58 different validated secondary metabolite BGC types. antiSMASH 6.0 has further improved the number of BGC types detected to 71. antiSMASH 3.0 (Weber et al., <xref rid="bib93" ref-type="bibr">2015</xref>) incorporated MIBiG (Medema et al., <xref rid="bib63" ref-type="bibr">2015</xref>; see below) to improve comparative analyses of assigned BGCs to known BGCs. It also incorporated ClusterFinder (Cimermancic et al., <xref rid="bib26" ref-type="bibr">2014</xref>), a feature that provided an optional search of genome sequences for more speculative, unvalidated secondary metabolite BGCs (Baltz, <xref rid="bib10" ref-type="bibr">2019</xref>). The speculative nature of ClusterFinder hits (CF_saccharides, CF_fatty acids, and CF_putatives) was not explained well in the initial publications, and many antiSMASH users interpreted all ClusterFinder hits as legitimate BGCs, resulting in erroneous interpretations of the data (Baltz, <xref rid="bib10" ref-type="bibr">2019</xref>). The original concept of ClusterFinder was for use as a research tool to help discover totally new types of secondary metabolites, and not as a validated search method for drug discovery. The use of antiSMASH 3.0 with ClusterFinder OFF was a useful method to search finished microbial genomes for validated secondary metabolite BGCs and was used effectively to identify the most gifted microorganisms to pursue drug discovery (Baltz, <xref rid="bib6" ref-type="bibr">2017a</xref>, <xref rid="bib8" ref-type="bibr">2017c</xref>). antiSMASH analysis of many of the same gifted and nongifted microbes with ClusterFinder ON was also evaluated, and total BGC numbers were inflated by 1.3- to 17-fold, depending on genome size and on whether the microbe was naturally gifted (or not) for secondary metabolite BGC content (Baltz, <xref rid="bib10" ref-type="bibr">2019</xref>). The largest discrepancies were observed in microbes with small genomes encoding small numbers of legitimate BGCs, thus giving rise to grossly misleading interpretations on the suitability of certain microbes to serve as robust sources of BGCs for genome mining (Baltz, <xref rid="bib10" ref-type="bibr">2019</xref>). Importantly, antiSMASH 5.0 (Blin et al., <xref rid="bib19" ref-type="bibr">2019</xref>) removed ClusterFinder from its menu of standard options, so this source of artifactual unvalidated &#x0201c;BGCs&#x0201d; has been mitigated. This serves as a major improvement in the front end of the genome mining process for drug discovery.</p></sec><sec id="sec7-2"><title>The antiSMASH database</title><p>The antiSMASH database is an important adjunct to the antiSMASH bioinformatics tool. Whereas antiSMASH analyzes and annotates individual microbial genomes, the antiSMASH database makes precomputed antiSMASH data from many microbes instantly available for comparative studies. It contains BGCs from 25,236 high-quality bacterial, 388 archaeal, and 177 fungal genomes, and has been incorporated into antiSMASH 5.0 as a ClusterBlast search option. This can be used in conjunction with the KnownClusterBlast option to compare BGCs with manually curated known BGCs from MIBiG 2.0 (Kautsar et al., <xref rid="bib53" ref-type="bibr">2020</xref>).</p></sec><sec id="sec7-3"><title>MIBiG</title><p>The MIBiG bioinformatics tool was developed by a collaborative effort of many scientists from around the world to standardize information about relationships between known secondary metabolites and their characterized BGCs (Medema et al., <xref rid="bib63" ref-type="bibr">2015</xref>). The authors anticipated that MIBiG would help scientists to connect genes and chemical structures and vice versa, to better understand secondary metabolite biosynthesis, to serve as an evidence-based parts registry for secondary metabolite biosynthetic genes that can be drawn upon for modification of existing biosynthetic pathways and for designing new pathways. From a drug discovery perspective, the MIBiG bioinformatics tool also serves to dereplicate known BGCs and helps identify new and novel BGCs when coupled with antiSMASH. The initial database contained 1,170 BGCs annotated with a minimal number of parameters. Of these, 405 BGCs were more fully annotated by 81 academic groups and some companies worldwide, and the authors anticipated further curation efforts to more fully annotate the other 765 BGCs. MIBiG 2.0 was recently published (Kautsar et al., <xref rid="bib53" ref-type="bibr">2020</xref>). Over the span of 5 years, 851 new BGCs have been added to the database, and all entries have undergone extensive re-annotation to increase the overall quality of data. The online repository of BGC data has new functionalities to make the extraction of information more user-friendly. Importantly, MIBiG 2.0 is imbedded in antiSMASH 5.0 and 6.0, and in IMG-ABC 5.0 for rapid whole-genome analyses.</p></sec><sec id="sec7-4"><title>IMG-ABC</title><p>The <italic toggle="yes">i</italic>ntegrated <italic toggle="yes">m</italic>icrobial <italic toggle="yes">g</italic>enomes <italic toggle="yes">a</italic>tlas of <italic toggle="yes">b</italic>iosynthetic gene <italic toggle="yes">c</italic>lusters (IMG-ABC) of the Joint Genome Institute (JGI) of the Department of Energy was developed to couple computational searching of large genomic datasets with the discovery of small molecules (Hadjithomas et al., <xref rid="bib42" ref-type="bibr">2015</xref>). At the time, it was the largest repository of information on potential secondary metabolite BGCs and contained about 1000 BGCs that were linked to known structures in the MIBiG database (Medema et al., <xref rid="bib63" ref-type="bibr">2015</xref>), and about 900,000 possible BGCs not linked to chemical structures. This massive number of possible BGCs included very large numbers of putative BGCs generated by ClusterFinder analysis using earlier versions of antiSMASH (Hadjithomas et al., <xref rid="bib42" ref-type="bibr">2015</xref>, <xref rid="bib43" ref-type="bibr">2017</xref>), as well as fragmented NRPS and PKS-I BGCs generated by Illumina sequencing (Baltz, <xref rid="bib8" ref-type="bibr">2017c</xref>). The lack of validation of ClusterFinder as a predictor of legitimate secondary metabolite BGCs has been addressed recently (Baltz, <xref rid="bib10" ref-type="bibr">2019</xref>). The developers of antiSMASH have recently come to the same conclusions on putative BGCs, and have removed the ClusterFinder option in antiSMASH 5.0 and 6.0. The most recent version of IMG-ABC (v.5.0) has also addressed the problem of unvalidated BGCs generated by ClusterFinder by reanalyzing all genomes by antiSMASH 5.0 and discarding all putative BGCs annotated by earlier versions of antiSMASH with ClusterFinder ON (Palaniappan et al., <xref rid="bib76" ref-type="bibr">2020</xref>). The current database contains 1,285 experimentally verified BGCs from MIBiG 2.0 (Kautsar et al., <xref rid="bib53" ref-type="bibr">2020</xref>), as well as 317,423 predicted BGCs from 42,892 publically available microbial genomes, and 12,176 predicted BGCs from 4,944 high-quality scaffold bins and other uncultured microbes. These numbers are not artificially inflated by putative BGCs as in the early versions of IMG-ABC (Hadjithomas et al., <xref rid="bib42" ref-type="bibr">2015</xref>, <xref rid="bib43" ref-type="bibr">2017</xref>), and are more in line with BGC numbers derived by antiSMASH 3.0 with ClusterFinder OFF (Baltz, <xref rid="bib6" ref-type="bibr">2017a</xref>, <xref rid="bib8" ref-type="bibr">2017c</xref>). This upgrade in IMG-ABC 5.0 is a major advancement in quality that will serve the natural products community and drug discovery efforts well in the coming years.</p></sec></sec><sec id="sec8"><title>Examples of genome mining by exploiting evolutionary relationships and molecular beacons</title><p>In order to effectively mine microbial genomes for new and novel natural product BGCs, it is critical that we understand the evolutionary relationships between BGCs, particularly those most likely to have druglike properties. Natural products that have been successfully developed for human medicine, animal health, and plant crop protection are dominated by large molecules biosynthesized by NRPS, PKS-I, and mixed NRPS/PKS-I mechanisms (Katz &#x00026; Baltz, <xref rid="bib51" ref-type="bibr">2016</xref>; Baltz, <xref rid="bib8" ref-type="bibr">2017c</xref>, 2019) (Table S1). Since these utilize very large, multimodular, multienzymes, they are subject to evolutionary divergence over millions of years to generate natural combinatorial groupings of somewhat related biosynthetic products. One approach to microbial genome mining is to identify sets of BGCs that are related to known natural products with important clinical applications. For the purposes of this perspective, I review three examples that employ NRPS/PKS-I mechanisms: glycopeptides related to vancomycin, mixed NRP-PKs related to rapamycin and FK506, and lipopeptides related to daptomycin.</p></sec><sec id="sec9"><title>Glycopeptides related to vancomycin</title><p>It has been known for decades that antibiotic-producing actinomycetes typically encode self-resistance mechanisms to avoid suicide (Cundliffe &#x00026; Demain, <xref rid="bib28" ref-type="bibr">2010</xref>). The resistance genes typically reside within antibiotic BGCs and can function by a number of mechanisms, including target modification, antibiotic modification, efflux, and duplication of a gene that encodes the antibiotic target, followed by the divergence of one gene copy to encode an antibiotic-resistant target that expresses dominance in the presence of the antibiotic. The gene duplication mechanism can be searched bioinformatically for the presence of second copies of housekeeping genes located in cryptic BGCs. Such BGCs are likely to encode novel mechanisms of action and can be prioritized for antibiotic discovery (Mungen et al., <xref rid="bib67" ref-type="bibr">2020</xref>).</p><p>Vancomycin is an important glycopeptide antibiotic used to treat infections caused by Gram-positive pathogens, including methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> (MRSA). Other clinically approved glycopeptides or lipoglycopeptides related to vancomycin are teicoplanin, oritavancin (a semisynthetic derivative of chloroeremomycin), dalbavancin, and telavancin (David &#x00026; Daum, <xref rid="bib29" ref-type="bibr">2017</xref>; Lampejo, <xref rid="bib57" ref-type="bibr">2020</xref>). Many semisynthetic derivatives of glycopeptides have been evaluated over the years (Malabarba et al. <xref rid="bib61" ref-type="bibr">1997</xref>). Because of their common mechanisms of action, they all have resistance mechanisms to remodel peptidoglycan to interfere with target binding. Thus, many additional glycopeptide antibiotics have been discovered by selecting soil-dwelling actinomycetes for vancomycin resistance (Thaker et al., <xref rid="bib84" ref-type="bibr">2013</xref>, <xref rid="bib85" ref-type="bibr">2014</xref>).</p><p>Gerry Wright and colleagues have studied the phylogenic relationships between the known glycopeptide antibiotic BGCs, as well as other related glycopeptide BGCs identified by genome mining (Waglechner et al., <xref rid="bib90" ref-type="bibr">2019</xref>). The glycopeptides have diverse chemical structures and complex phylogenetic relationships. The core NRPS-derived heptapeptide structure evolved about 300 to 500 million years ago. While many of the 71 BGCs examined contained typical vancomycin-resistance genes (<italic toggle="yes">vanHAX</italic>), others did not. They reasoned that the glycopeptides lacking vancomycin resistance genes may function by different mechanism(s) of action. They showed that the known glycopeptide, complestatin, and the newly discovered corbomycin BGCs are present in clades of five and four, respectively, of the 21 glycopeptide BGCs lacking vancomycin-resistance genes (Culp et al., <xref rid="bib27" ref-type="bibr">2020</xref>). They studied the mechanism of action of these potent antibiotics with Gram-positive activities and demonstrated that they inhibit peptidoglycan remodelling during cell division by binding to peptidoglycan and blocking the activities of multiple autolysins. This novel mechanism of action is not subject to single-step mutations to high-level antibiotic resistance. Importantly, these antibiotics are active against multidrug-resistant clinical isolates and present interesting scaffolds for further development.</p></sec><sec id="sec10"><title>Rapamycin/FK506 analogs</title><p>Rapamycin (sirolimus) and FK506 (tacrolimus) are structurally related molecules biosynthesized by hybrid NRPS/PKS-I mechanisms. They have potent immunomodulatory activities approved for prophylaxis of organ transplant rejection (Ban et al., <xref rid="bib12" ref-type="bibr">2016</xref>; Yoo et al., <xref rid="bib96" ref-type="bibr">2017</xref>). Rapamycin and FK506 function mechanistically by facilitating protein&#x02013;protein interactions between a ubiquitous peptidyl prolyl isomerase, FK506-binding protein (FKBP12), with mTOR and calcineurin, respectively. Both molecules have a constant region for binding FKBP12, and a variable region for binding mTOR or calcineurin. They both incorporate pipecolic acid in the constant region, and their BGCs include genes encoding lysine cyclodeaminase (KCDA) to convert <sc>l</sc>-lysine to <sc>l</sc>-pipecolic acid (Ban et al., <xref rid="bib12" ref-type="bibr">2016</xref>; Yoo et al., <xref rid="bib96" ref-type="bibr">2017</xref>). Scientists at Warp Drive Bio reasoned that this unique mechanism to facilitate protein&#x02013;protein interactions to inhibit the activities of proteins involved in immune responses might also be programmed to modulate other proteins by chemical variations in the variable region. Such variations might already have evolved in nature, and can also be generated in the laboratory by combinatorial biosynthesis. To search for novel compounds related to rapamycin and FK506, they sequenced approximately 135,000 actinomycete genomes in pools, then deconvoluted those with KCDA genes. They obtained high-quality genome sequences from the strains by a combination of Illumina and PacBio sequencing to assemble the BGCs (Shigdel et al., <xref rid="bib81" ref-type="bibr">2020</xref>). Over 40 strains had rapamycin or FK506 BGCs, and other strains encoded seven novel chemical scaffolds related to rapamycin and FK506. WDB002, produced by <italic toggle="yes">Streptomyces malaysiensis</italic>, had a smaller variable region than rapamycin and FK506. It binds to FKBP12 to form a binary complex which then binds to the human centrosomal protein, CEP250, to form a ternary complex. The CEP250 binding site is a flat coiled coil, a type of protein domain previously not considered to be druggable by small molecules. The authors suggest that FKBP12-assisted ternary complex formation represents a promising approach to drug previously undruggable targets. In a recent study on interactions between human proteins and viral proteins expressed during COVID-19 infections, CEP250 was identified as a host protein that interacts with the viral protein Nsp13 (Gordon et al., <xref rid="bib39" ref-type="bibr">2020</xref>). This suggests the possibility that WDB002 might have COVID-19 inhibitory activity via CEP250 ternary complex formation (Shigdel et al., <xref rid="bib81" ref-type="bibr">2020</xref>).</p></sec><sec id="sec11"><title>Lipopeptides related to daptomycin</title><p>Daptomycin (Cubicin) is a cyclic lipopeptide antibiotic produced by <italic toggle="yes">S. roseosporus</italic>. It is approved to treat complicated skin and skin structure infections (SSSI) caused by Gram-positive pathogens, and <italic toggle="yes">S. aureus</italic> bacteremia, including right-sided endocarditis (Eisenstein et al., <xref rid="bib32" ref-type="bibr">2010</xref>). The biosynthesis of daptomycin is well understood, and many derivatives have been produced by semisynthesis and combinatorial biosynthesis (Baltz, <xref rid="bib4" ref-type="bibr">2014</xref>, <xref rid="bib11" ref-type="bibr">2021</xref>). The phylogenetic relationships between diverse lipopeptides have revealed that they employ biosynthetic mechanisms highly suitable for natural evolution, laboratory-based combinatorial biosynthesis, and divergence in the mechanism of action (Baltz, <xref rid="bib11" ref-type="bibr">2021</xref>). The latter may be facilitated by the apparent use of ABC transporters as the sole, target-agnostic mechanisms of resistance. Lipopeptide assembly initiates with the attachment of a long-chain fatty acid to the first amino acid by a mechanism that utilizes a fatty acyl-AMP ligase (FAAL), a free-standing acyl carrier protein (ACP), and a specialized NRPS condensation (<sup>III</sup>C) domain (Baltz, <xref rid="bib11" ref-type="bibr">2021</xref>). After peptide chain elongation, the nascent lipopeptide is cyclized and released by a thioesterase (Te) domain located on a terminal CAT-CATTe di-modular NRPS. These initiation and termination mechanisms are observed in BGCs encoding daptomycin, taromycin, A54145, friulimicin, laspartomycin, malacidin, and telomycin (Baltz, <xref rid="bib11" ref-type="bibr">2021</xref>). The FAAL, ACP, and di-modular NRPS genes have been used as molecular beacons to search for other uncharacterized lipopeptide BGCs in NCBI. A novel lipopeptide BGC was identified in the finished genome of <italic toggle="yes">Streptomyces ambofaciens</italic>, a fragmented BGC related to that of daptomycin was identified in the draft genome of <italic toggle="yes">Streptomyces sedi</italic>, and a fragmented, but likely novel, lipopeptide BGC was identified in the draft genome of <italic toggle="yes">Streptomyces zhaozhouensis</italic> (Baltz, <xref rid="bib11" ref-type="bibr">2021</xref>). This study identified three potentially interesting lipopeptide BGCs for further expression, chemical characterization, and biological activity studies. In two of the cases, the identification of likely new lipopeptide BGCs in <italic toggle="yes">S. sedi and S. zhaozhouensis</italic> serve as examples of the use of molecular &#x0201c;beacon&#x0201d; analysis to prioritize strains with draft genome sequences for finishing.</p></sec><sec id="sec12"><title>Perspective</title><p>By the middle of the first decade of the 21st Century, it was becoming clear that microbial genome mining could become a major driver to revitalize a moribund natural products discovery and development industry (Baltz, <xref rid="bib3" ref-type="bibr">2008</xref>). In the ensuing years, major advances in genome sequencing technology, bioinformatics, metabolomics, and synthetic biology have accelerated the discovery of new and novel secondary metabolite BGCs for drug development, and are providing an unprecedented source of genetic parts and devices for synthetic biology approaches to combinatorial biosynthesis of complex molecules assembled by NRPS, PKS-I, or mixed NRPS/PKS-I pathways (Baltz, <xref rid="bib9" ref-type="bibr">2018</xref>; Yuzawa et al., <xref rid="bib97" ref-type="bibr">2018</xref>; Iacovelli et al., <xref rid="bib45" ref-type="bibr">2021</xref>; Whitford et al., <xref rid="bib94" ref-type="bibr">2021</xref>). As with any new technology, advancements are often driven by hypotheses and conjectures that need to be validated or rejected as misconceptions (Baltz, <xref rid="bib10" ref-type="bibr">2019</xref>). Unvalidated conjectures can become the anchors that impede progress if they are in fact misconceptions. Three such conjectures have been recently shown to be misconceptions, one persisting over the last two decades, and two generated during the genomic era (Baltz, <xref rid="bib10" ref-type="bibr">2019</xref>). The first misconception is that unculturable microbes will provide an abundant new source of natural products for drug discovery. It is now well established that culturable microbes with large genomes are the most &#x0201c;gifted&#x0201d; for natural product drug discovery, and unculturable microbes with small genomes are very poor sources (Baltz, <xref rid="bib6" ref-type="bibr">2017a</xref>, <xref rid="bib8" ref-type="bibr">2017c</xref>, <xref rid="bib10" ref-type="bibr">2019</xref>). The most gifted are the filamentous actinomycetes and myxobacteria. The second misconception from the genomic era is that the ClusterFinder feature of antiSMASH 3.0 identifies potential BGCs for drug discovery. Misinterpretation of this unvalidated conjecture has led to erroneous overcounting of &#x0201c;BGCs&#x0201d; in ungifted microbes and to the accumulation of unnecessary &#x0201c;genomic noise&#x0201d; in the original IMG-ABC database (Baltz, <xref rid="bib8" ref-type="bibr">2017c</xref>, <xref rid="bib10" ref-type="bibr">2019</xref>). This issue has been addressed by removing the ClusterFinder feature as an option from antiSMASH 5.0 (Blin et al., <xref rid="bib17" ref-type="bibr">2019</xref>), and revamping the IMG-ABC database (Palaniappan et al., <xref rid="bib76" ref-type="bibr">2020</xref>). These two major advancements will release the drug discovery process from a major misconception that has been impeding progress on mining legitimate secondary metabolite BGCs. The third misconception derived from advances on short read, inexpensive genome sequencing is that &#x0201c;high-quality draft genomes&#x0201d; are sufficient to identify druglike secondary metabolite BGCs. It is now well established that draft genome sequences typically contain misassemblies of NRPS and PKS-I BGCs, the most important ongoing source of important scaffolds for drug discovery. Whereas the numbers of finished genomes of actinomycetes and myxobacteria available at NCBI have increased over the past 4 years, they remain dwarfed by the numbers of draft genomes. DNA sequencing technology has advanced substantially with PacBio and Oxford Nanopore long-read sequencing that complement Illumina short-read sequencing to obtain finished-quality genome sequences from large microbial genomes that encode multiple druglike secondary metabolites biosynthesized by NRPS and PKS-I mechanisms. Building a much larger public database of finished genomes from known producers of important secondary metabolites will be very important to continue improving bioinformatic tools such as MIBig, IMG-ABC, and antiSMASH. Finishing multiple draft genome sequences from other gifted actinomycetes and myxobacteria, perhaps starting with strains encoding potentially novel BGCs identified by molecular beacon analysis, will also augment the drug discovery process.</p><p>In summary, microbial genome mining for drug discovery and development is a nine-step process, and optimizing the first two steps is critical to develop a robust process. Identification and correction of the three major misconceptions at the front end of the process will undoubtedly help streamline a productive microbial genome mining process for drug discovery. An immediate opportunity to improve the process is to generate finished-quality genome sequences of gifted microbes that produce known important secondary metabolites and deposit them in publically available databases to facilitate rapid bioinformatic dereplication and discovery of BGCs encoding new and novel compounds derived from NRPS, PKS-I, and other biosynthetic mechanisms. This will enhance the utility of antiSMASH, MIBiG, and IMG-ABC for all academic and industrial discovery activities. In the long term, finished-quality genome sequences from truly gifted microbes for drug discovery should become the norm, not the exception.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="sup1" position="float" content-type="local-data"><label>kuab044_Supplemental_File</label><media xlink:href="kuab044_supplemental_file.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="ack1"><title>Acknowledgments</title><p>I would like to thank many scientific colleagues for fruitful discussions on different aspects of microbial genome mining, these include: Brian Bachmann, Josh Blodgett, Marc Chevrette, Cameron Currie, Michael Fischbach, Lucy Foulston, Neil Kelliher, Bill Metcalf, Nigel Mouncey, Rolf M&#x000fc;ller, Keith Robison, Ben Shen, Dan Udwary, Gilles Van Wezel, Steve Van Lanen, Greg Verdine, Tilmann Weber, and Gerry Wright. This perspective is dedicated to the memory of Arny Demain, a champion for natural products, open communication, and international collaboration to progress industrial microbiology and biotechnology to meet the needs of mankind. He was a role model as a scientist, teacher, mentor, humanitarian, and friend.</p></ack><sec id="sec14"><title>Funding</title><p>None declared.</p></sec><sec id="sec15"><title>Conflict of interest</title><p>The author declares no conflict of interest.</p></sec><ref-list id="ref1"><title>References</title><ref id="bib1"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Aigle</surname>
<given-names>B.</given-names>
</string-name>, <string-name><surname>Lautru</surname><given-names>S.</given-names></string-name>, <string-name><surname>Spiteller</surname><given-names>D.</given-names></string-name>, <string-name><surname>Dickshat</surname><given-names>J. S.</given-names></string-name>, <string-name><surname>Challis</surname><given-names>G. L.</given-names></string-name>, <string-name><surname>Leblond</surname><given-names>P.</given-names></string-name>, <string-name><surname>Pernodet</surname><given-names>J. L.</given-names></string-name></person-group> (<year>2014</year>). <article-title>Genome mining in <italic toggle="yes">Streptomyces ambofaciens</italic></article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>41</volume>(<issue>2</issue>), <fpage>251</fpage>&#x02013;<lpage>263</lpage>.<pub-id pub-id-type="pmid">24258629</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bachmann</surname>
<given-names>B. O.</given-names>
</string-name>, <string-name><surname>Van Lanen</surname><given-names>S. G.</given-names></string-name>, <string-name><surname>Baltz</surname><given-names>R. H.</given-names></string-name></person-group> (<year>2014</year>). <article-title>Microbial genome mining for accelerated natural products discovery: Is a renaissance in the making?</article-title><source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>41</volume>(<issue>2</issue>), <fpage>175</fpage>&#x02013;<lpage>184</lpage>.<pub-id pub-id-type="pmid">24342967</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Baltz</surname>
<given-names>R. H.</given-names>
</string-name>
</person-group> (<year>2008</year>). <article-title>Renaissance in antibacterial discovery from actinomycetes</article-title>. <source>Current Opinion in Pharmacology</source>, <volume>8</volume>(<issue>5</issue>), <fpage>557</fpage>&#x02013;<lpage>563</lpage>.<pub-id pub-id-type="pmid">18524678</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Baltz</surname>
<given-names>R. H.</given-names>
</string-name>
</person-group> (<year>2014</year>). <article-title>Combinatorial biosynthesis of cyclic lipopeptide antibiotics: A model for synthetic biology to accelerate the evolution of secondary metabolite biosynthetic pathways</article-title>. <source>ACS Synthetic Biology</source>, <volume>3</volume>(<issue>10</issue>), <fpage>748</fpage>&#x02013;<lpage>758</lpage>.<pub-id pub-id-type="pmid">23654258</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Baltz</surname>
<given-names>R. H.</given-names>
</string-name>
</person-group> (<year>2016</year>). <article-title>Genetic manipulation of secondary metabolite biosynthesis for improved production in <italic toggle="yes">Streptomyces</italic> and other actinomycetes</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>43</volume>(<issue>2-3</issue>), <fpage>343</fpage>&#x02013;<lpage>370</lpage>.<pub-id pub-id-type="pmid">26364200</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Baltz</surname>
<given-names>R. H.</given-names>
</string-name>
</person-group> (<year>2017a</year>). <article-title>Gifted microbes for genome mining and natural product discovery</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>44</volume>(<issue>4&#x02013;5</issue>), <fpage>573</fpage>&#x02013;<lpage>588</lpage>.<pub-id pub-id-type="pmid">27520548</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Baltz</surname>
<given-names>R. H.</given-names>
</string-name>
</person-group> (<year>2017b</year>). <article-title>Molecular beacons to identify gifted microbes for genome mining</article-title>. <source>The Journal of Antibiotics</source>, <volume>70</volume>(<issue>5</issue>), <fpage>639</fpage>&#x02013;<lpage>646</lpage>.<pub-id pub-id-type="pmid">28119518</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Baltz</surname>
<given-names>R. H.</given-names>
</string-name>
</person-group> (<year>2017c</year>). <article-title>Microbial genome mining for natural product drug discovery</article-title>. In <person-group person-group-type="editor"><string-name><surname>Newman</surname><given-names>D. J.</given-names></string-name>, <string-name><surname>Cragg</surname><given-names>G. M.</given-names></string-name>, <string-name><surname>Grothaus</surname><given-names>P. G.</given-names></string-name></person-group> (Eds.) <source>Chemical Biology of Natural Products</source> (pp. <fpage>1</fpage>&#x02013;<lpage>42</lpage>). <publisher-name>CRC Press</publisher-name>, <publisher-loc>Boca Raton</publisher-loc>.</mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Baltz</surname>
<given-names>R. H.</given-names>
</string-name>
</person-group> (<year>2018</year>). <article-title>Synthetic biology, genome mining, and combinatorial biosynthesis of NRPS-derived antibiotics: A perspective</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>45</volume>(<issue>7</issue>), <fpage>635</fpage>&#x02013;<lpage>649</lpage>.<pub-id pub-id-type="pmid">29288438</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Baltz</surname>
<given-names>R. H.</given-names>
</string-name>
</person-group> (<year>2019</year>). <article-title>Natural product drug discovery in the genomic era: Realities, conjectures, misconceptions, and opportunities</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>46</volume>(<issue>3&#x02013;4</issue>), <fpage>281</fpage>&#x02013;<lpage>299</lpage><pub-id pub-id-type="pmid">30484124</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Baltz</surname>
<given-names>R. H.</given-names>
</string-name>
</person-group> (<year>2021</year>). <article-title>Genome mining for drug discovery: Cyclic lipopeptides related to daptomycin</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>48</volume>(<issue>3&#x02013;4</issue>), <comment>doi: 10.1093/jimb/kuab020</comment>.</mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ban</surname>
<given-names>Y. H.</given-names>
</string-name>, <string-name><surname>Park</surname><given-names>S. R.</given-names></string-name>, <string-name><surname>Yoon</surname><given-names>Y. J.</given-names></string-name></person-group> (<year>2016</year>). <article-title>The biosynthetic pathway for FK506 and its engineering: From past achievements to future prospects</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>43</volume>(<issue>2&#x02013;3</issue>), <fpage>389</fpage>&#x02013;<lpage>400</lpage>.<pub-id pub-id-type="pmid">26342319</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bentley</surname>
<given-names>S. D.</given-names>
</string-name>, <string-name><surname>Chater</surname><given-names>K. F.</given-names></string-name>, <string-name><surname>Cerde&#x000f1;o-T&#x000e1;rraga</surname><given-names>A. M.</given-names></string-name>, <string-name><surname>Challis</surname><given-names>G. L.</given-names></string-name>, <string-name><surname>Thomson</surname><given-names>N. R.</given-names></string-name>, <string-name><surname>James</surname><given-names>K. D.</given-names></string-name>, <string-name><surname>Harris</surname><given-names>D. E.</given-names></string-name>, <string-name><surname>Quail</surname><given-names>M. A.</given-names></string-name>, <string-name><surname>Kieser</surname><given-names>H.</given-names></string-name>, <string-name><surname>Harper</surname><given-names>D.</given-names></string-name>, <string-name><surname>Bateman</surname><given-names>A.</given-names></string-name>, <string-name><surname>Brown</surname><given-names>S.</given-names></string-name>, <string-name><surname>Chandra</surname><given-names>G.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>C. W.</given-names></string-name>, <string-name><surname>Collins</surname><given-names>M.</given-names></string-name>, <string-name><surname>Cronin</surname><given-names>A.</given-names></string-name>, <string-name><surname>Fraser</surname><given-names>A.</given-names></string-name>, <string-name><surname>Goble</surname><given-names>A.</given-names></string-name>, <string-name><surname>Hidalgo</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hopwood</surname><given-names>D. A.</given-names></string-name></person-group> (<year>2002</year>). <article-title>Complete genome sequence of the model actinomycete <italic toggle="yes">Streptomyces coelicolor</italic> A3(2)</article-title>. <source>Nature</source>, <volume>417</volume>(<issue>6885</issue>), <fpage>141</fpage>&#x02013;<lpage>147</lpage>.<pub-id pub-id-type="pmid">12000953</pub-id></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Blin</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Medema</surname><given-names>M. H.</given-names></string-name>, <string-name><surname>Kazempour</surname><given-names>D.</given-names></string-name>, <string-name><surname>Fischbach</surname><given-names>M. A.</given-names></string-name>, <string-name><surname>Breitling</surname><given-names>R.</given-names></string-name>, <string-name><surname>Takano</surname><given-names>E.</given-names></string-name>, <string-name><surname>Weber</surname><given-names>T.</given-names></string-name></person-group> (<year>2013</year>). <article-title>antiSMASH 2.0 - a versatile platform for genome mining of secondary metabolite producers</article-title>. <source>Nucleic Acids Research</source>, <volume>41</volume>(<issue>W1</issue>), <fpage>W204</fpage>&#x02013;<lpage>W212</lpage>.<pub-id pub-id-type="pmid">23737449</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Blin.</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Wolf</surname><given-names>T.</given-names></string-name>, <string-name><surname>Chevrette</surname><given-names>M. G</given-names></string-name>, <string-name><surname>Lu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Schwalen</surname><given-names>C. J.</given-names></string-name>, <string-name><surname>Kautsar</surname><given-names>S. A.</given-names></string-name>, <string-name><surname>Duran</surname><given-names>H. G. S.</given-names></string-name>, <string-name><surname>de Los Santos</surname><given-names>E. L. C.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>H. U.</given-names></string-name>, <string-name><surname>Nave</surname><given-names>M.</given-names></string-name>, <string-name><surname>Dickschat</surname><given-names>J. S.</given-names></string-name>, <string-name><surname>Mitchell</surname><given-names>D. A.</given-names></string-name>, <string-name><surname>Shelest</surname><given-names>E.</given-names></string-name>, <string-name><surname>Breitling</surname><given-names>R.</given-names></string-name>, <string-name><surname>Takano</surname><given-names>E.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>S. Y.</given-names></string-name>, <string-name><surname>Weber</surname><given-names>T.</given-names></string-name>, <string-name><surname>Medema</surname><given-names>M. H.</given-names></string-name></person-group> (<year>2017</year>). <article-title>antiSMASH 4.0 &#x02013; improvements in chemistry prediction and gene cluster boundary identification</article-title>. <source>Nucleic Acids Research</source>, <volume>45</volume>(<issue>W1</issue>), <fpage>W36</fpage>&#x02013;<lpage>W41</lpage>.<pub-id pub-id-type="pmid">28460038</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Blin</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Medema</surname><given-names>M. H.</given-names></string-name>, <string-name><surname>Kottmann</surname><given-names>R.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>S. Y.</given-names></string-name>, <string-name><surname>Weber</surname><given-names>T.</given-names></string-name></person-group> (<year>2017</year>). <article-title>The antiSMASH database, a comprehensive database of microbial secondary metabolite biosynthetic gene clusters</article-title>. <source>Nucleic Acids Research</source>, <volume>45</volume>(<issue>D1</issue>), <fpage>D555</fpage>&#x02013;<lpage>D559</lpage>.<pub-id pub-id-type="pmid">27924032</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Blin</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Kim</surname><given-names>H. U.</given-names></string-name>, <string-name><surname>Medema</surname><given-names>M. H.</given-names></string-name>, <string-name><surname>Weber</surname><given-names>T.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Recent development of antiSMASH and other computational approaches to mine secondary metabolite biosynthetic gene clusters</article-title>. <source>Briefings in Bioinformatics</source><volume>20</volume>(<issue>4</issue>), <fpage>1103</fpage>&#x02013;<lpage>1113</lpage>.<pub-id pub-id-type="pmid">29112695</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Blin</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Shaw</surname><given-names>S.</given-names></string-name>, <string-name><surname>Steinke</surname><given-names>K.</given-names></string-name>, <string-name><surname>Villebro</surname><given-names>R.</given-names></string-name>, <string-name><surname>Ziemert</surname><given-names>N.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>S. Y.</given-names></string-name>, <string-name><surname>Medema</surname><given-names>M. H.</given-names></string-name>, <string-name><surname>Weber</surname><given-names>T.</given-names></string-name></person-group> (<year>2019</year>). <article-title>antiSMASH 5.0: Updates to the secondary metabolite genome mining pipeline</article-title>. <source>Nucleic Acids Research</source>, <volume>47</volume>(<issue>W1</issue>), <fpage>W81</fpage>&#x02013;<lpage>W87</lpage>.<pub-id pub-id-type="pmid">31032519</pub-id></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Blin</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Pascal Andreu</surname><given-names>V.</given-names></string-name>, <string-name><surname>de Los Santos</surname><given-names>E. L. C.</given-names></string-name>, <string-name><surname>Del Carratore</surname><given-names>F.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>S. Y.</given-names></string-name>, <string-name><surname>Medema</surname><given-names>M. H.</given-names></string-name>, <string-name><surname>Weber</surname><given-names>T.</given-names></string-name></person-group> (<year>2019</year>). <article-title>The antiSMASH database version 2.0: A comprehensive resource of secondary metabolite biosynthetic gene clusters</article-title>. <source>Nucleic Acids Research</source>, <volume>47</volume>(<issue>D1</issue>), <fpage>D625</fpage>&#x02013;<lpage>D630</lpage>.<pub-id pub-id-type="pmid">30395294</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Blin</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Shaw</surname><given-names>S.</given-names></string-name>, <string-name><surname>Kautsar</surname><given-names>S. A.</given-names></string-name>, <string-name><surname>Medema</surname><given-names>M. H.</given-names></string-name>, <string-name><surname>Weber</surname><given-names>T.</given-names></string-name></person-group> (<year>2021</year>). <article-title>The antiSMASH database version 3: Increased taxonomic coverage and new query features for modular enzymes</article-title>. <source>Nucleic Acids Research</source>, <volume>49</volume>(<issue>D1</issue>), <fpage>D639</fpage>&#x02013;<lpage>D643</lpage>.<pub-id pub-id-type="pmid">33152079</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Blin</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Shaw</surname><given-names>S.</given-names></string-name>, <string-name><surname>Kloosterman</surname><given-names>A. M.</given-names></string-name>, <string-name><surname>Charlop-Powers</surname><given-names>Z.</given-names></string-name>, <string-name><surname>van Wezel</surname><given-names>G. P.</given-names></string-name>, <string-name><surname>Medema</surname><given-names>M. H.</given-names></string-name>, <string-name><surname>Weber</surname><given-names>T.</given-names></string-name></person-group> (<year>2021</year>). <article-title>antiSMASH 6.0: Improving cluster detection and comparison capabilities</article-title>. <source>Nucleic Acids Research</source>, <volume>49</volume>(<issue>W1</issue>), <fpage>W29</fpage>&#x02013;<lpage>W35</lpage>, <comment>doi: 10.1093/nar/gkab335</comment>.<pub-id pub-id-type="pmid">33978755</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Challis</surname>
<given-names>G. L.</given-names>
</string-name>
</person-group> (<year>2014</year>). <article-title>Exploitation of the <italic toggle="yes">Streptomyces coelicolor</italic> A3(2) genome sequence for discovery of new natural products and biosynthetic pathways</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>41</volume>(<issue>2</issue>), <fpage>219</fpage>&#x02013;<lpage>232</lpage>.<pub-id pub-id-type="pmid">24322202</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chevrette</surname>
<given-names>M. G.</given-names>
</string-name>, <string-name><surname>Currie</surname><given-names>C. R.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Emerging evolutionary paradigms in antibiotic discovery</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>46</volume>(<issue>3&#x02013;4</issue>), <fpage>257</fpage>&#x02013;<lpage>271</lpage>.<pub-id pub-id-type="pmid">30269177</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chevrette</surname>
<given-names>M. G.</given-names>
</string-name>, <string-name><surname>Carlos-Shanley</surname><given-names>C.</given-names></string-name>, <string-name><surname>Louie</surname><given-names>K. B.</given-names></string-name>, <string-name><surname>Bowen</surname><given-names>B. P.</given-names></string-name>, <string-name><surname>Northern</surname><given-names>T. R.</given-names></string-name>, <string-name><surname>Currie</surname><given-names>C. R.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Taxonomic and metabolic incongruence in the ancient genus <italic toggle="yes">Streptomyces</italic></article-title>. <source>Frontiers in Microbiology</source>, <volume>10</volume>, <fpage>2170</fpage>.<pub-id pub-id-type="pmid">31616394</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chevrette</surname>
<given-names>M. G.</given-names>
</string-name>, <string-name><surname>Guti&#x000e9;rrez-Garc&#x000ed;a</surname><given-names>K.</given-names></string-name>, <string-name><surname>Selem-Mojica</surname><given-names>N.</given-names></string-name>, <string-name><surname>Aguilar-Mart&#x000ed;nez</surname><given-names>C.</given-names></string-name>, <string-name><surname>Ya&#x000f1;ez-Olvera</surname><given-names>A.</given-names></string-name>, <string-name><surname>Ramos-Aboites</surname><given-names>H. E.</given-names></string-name>, <string-name><surname>Paul A Hoskisson</surname><given-names>P. A.</given-names></string-name>, <string-name><surname>Barona-G&#x000f3;mez</surname><given-names>F.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Evolutionary dynamics of natural product biosynthesis in bacteria</article-title>. <source>Natural Product Reports</source>, <volume>37</volume>(<issue>4</issue>), <fpage>566</fpage>&#x02013;<lpage>599</lpage><pub-id pub-id-type="pmid">31822877</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cimermancic</surname>
<given-names>P.</given-names>
</string-name>, <string-name><surname>Medema</surname><given-names>M. H.</given-names></string-name>, <string-name><surname>Claesen</surname><given-names>J.</given-names></string-name>, <string-name><surname>Kurita</surname><given-names>K.</given-names></string-name>, <string-name><surname>Wieland Brown</surname><given-names>L. C.</given-names></string-name>, <string-name><surname>Mavrommatis</surname><given-names>K.</given-names></string-name>, <string-name><surname>Pati</surname><given-names>A.</given-names></string-name>, <string-name><surname>Godfrey</surname><given-names>P. A.</given-names></string-name>, <string-name><surname>Koehrsen</surname><given-names>M.</given-names></string-name>, <string-name><surname>Clardy</surname><given-names>J.</given-names></string-name>, <string-name><surname>Birren</surname><given-names>B. W.</given-names></string-name>, <string-name><surname>Takano</surname><given-names>E.</given-names></string-name>, <string-name><surname>Sali</surname><given-names>A.</given-names></string-name>, <string-name><surname>Linington</surname><given-names>R. G.</given-names></string-name>, <string-name><surname>Fischbach</surname><given-names>M. A.</given-names></string-name></person-group> (<year>2014</year>). <article-title>Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters</article-title>. <source>Cell</source>, <volume>158</volume>(<issue>2</issue>), <fpage>412</fpage>&#x02013;<lpage>421</lpage>.<pub-id pub-id-type="pmid">25036635</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Culp</surname>
<given-names>E. J.</given-names>
</string-name>, <string-name><surname>Waglechner</surname><given-names>N.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Fiebig-Comyn</surname><given-names>A. A.</given-names></string-name>, <string-name><surname>Hsu</surname><given-names>Y. P.</given-names></string-name>, <string-name><surname>Koteva</surname><given-names>K.</given-names></string-name>, <string-name><surname>Sychantha</surname><given-names>D.</given-names></string-name>, <string-name><surname>Van Nieuwenhze</surname><given-names>M. S.</given-names></string-name>, <string-name><surname>Brun</surname><given-names>Y. V.</given-names></string-name>, <string-name><surname>Wright</surname><given-names>G. D.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling</article-title>. <source>Nature</source><volume>578</volume>(<issue>7796</issue>), <fpage>582</fpage>&#x02013;<lpage>587</lpage>.<pub-id pub-id-type="pmid">32051588</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cundliffe</surname>
<given-names>E.</given-names>
</string-name>, <string-name><surname>Demain</surname><given-names>A. L.</given-names></string-name></person-group> (<year>2010</year>). <article-title>Avoidance of suicide in antibiotic-producing microbes</article-title>. <source>Journal of Industrial Microbiology &#x00026; Biotechnology</source>, <volume>37</volume>(<issue>7</issue>), <fpage>643</fpage>&#x02013;<lpage>672</lpage>.<pub-id pub-id-type="pmid">20446033</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>David</surname>
<given-names>M. Z.</given-names>
</string-name>, <string-name><surname>Daum</surname><given-names>R. S.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Treatment of <italic toggle="yes">Staphylococcus aureus</italic> infections</article-title>. <source>Current Topics in Microbiology and Immunology</source>, <volume>409</volume>, <fpage>325</fpage>&#x02013;<lpage>383</lpage>.<pub-id pub-id-type="pmid">28900682</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Demain</surname>
<given-names>A. L.</given-names>
</string-name>
</person-group> (<year>2014</year>). <article-title>Importance of microbial natural products and the need to revitalize their discovery</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>41</volume>(<issue>2</issue>), <fpage>185</fpage>&#x02013;<lpage>201</lpage>.<pub-id pub-id-type="pmid">23990168</pub-id></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Doroghazi</surname>
<given-names>J. R.</given-names>
</string-name>, <string-name><surname>Albright</surname><given-names>J. C.</given-names></string-name>, <string-name><surname>Goering</surname><given-names>A. W.</given-names></string-name>, <string-name><surname>Ju</surname><given-names>K. S.</given-names></string-name>, <string-name><surname>Haines</surname><given-names>R. R.</given-names></string-name>, <string-name><surname>Tchalukov</surname><given-names>K. A.</given-names></string-name>, <string-name><surname>Labeda</surname><given-names>D. P.</given-names></string-name>, <string-name><surname>Kelleher</surname><given-names>N. L.</given-names></string-name>, <string-name><surname>Metcalf</surname><given-names>W. W.</given-names></string-name></person-group> (<year>2014</year>). <article-title>A roadmap for natural product discovery based on large-scale genomics and metabolomics</article-title>. <source>Nature Chemical Biology</source>, <volume>10</volume>(<issue>11</issue>), <fpage>963</fpage>&#x02013;<lpage>968</lpage>.<pub-id pub-id-type="pmid">25262415</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Eisenstein</surname>
<given-names>B. I.</given-names>
</string-name>, <string-name><surname>Oleson</surname><given-names>F. B.</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Baltz</surname><given-names>R. H.</given-names></string-name></person-group> (<year>2010</year>). <article-title>Daptomycin: From the mountain to the clinic, with essential help from Francis Tally, MD</article-title>. <source>Clinical Infectious Diseases</source>, <volume>50</volume>(<issue>s1</issue>), <fpage>S10</fpage>&#x02013;<lpage>S15</lpage>.<pub-id pub-id-type="pmid">20067387</pub-id></mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Foulston</surname>
<given-names>L.</given-names>
</string-name>
</person-group> (<year>2019</year>). <article-title>Genome mining and prospects for antibiotic discovery</article-title>. <source>Current Opinion in Microbiology</source>, <volume>51</volume>, <fpage>1</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">30776510</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Goering</surname>
<given-names>A. W.</given-names>
</string-name>, <string-name><surname>McClure</surname><given-names>R. A.</given-names></string-name>, <string-name><surname>Doroghazi</surname><given-names>J. R.</given-names></string-name>, <string-name><surname>Albright</surname><given-names>J. C.</given-names></string-name>, <string-name><surname>Haverland</surname><given-names>N. A.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ju</surname><given-names>K. S.</given-names></string-name>, <string-name><surname>Thomson</surname><given-names>R. J.</given-names></string-name>, <string-name><surname>Metcalf</surname><given-names>W. W.</given-names></string-name>, <string-name><surname>Kelleher</surname><given-names>N. L.</given-names></string-name></person-group> (<year>2016</year>). <article-title>Metabologenomics: Correlation of microbial gene clusters with metabolites drives discovery of a nonribosomal peptide with an unusual amino acid monomer</article-title>. <source>ACS Central Science</source>, <volume>2</volume>(<issue>2</issue>), <fpage>99</fpage>&#x02013;<lpage>108</lpage>.<pub-id pub-id-type="pmid">27163034</pub-id></mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Goldstein</surname>
<given-names>S.</given-names>
</string-name>, <string-name><surname>Beka</surname><given-names>L.</given-names></string-name>, <string-name><surname>Graf</surname><given-names>J.</given-names></string-name>, <string-name><surname>Klassen</surname><given-names>J. L.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Evaluation of strategies for the assembly of diverse bacterial genomes using MinION long-read sequencing</article-title>. <source>Bmc Genomics [Electronic Resource]</source>, <volume>20</volume>(<issue>1</issue>), <fpage>23</fpage>.</mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gomez-Escribano</surname>
<given-names>J. P.</given-names>
</string-name>, <string-name><surname>Castro</surname><given-names>J. F.</given-names></string-name>, <string-name><surname>Razmilic</surname><given-names>V.</given-names></string-name>, <string-name><surname>Chandra</surname><given-names>G.</given-names></string-name>, <string-name><surname>Andrews</surname><given-names>B.</given-names></string-name>, <string-name><surname>Bibb</surname><given-names>M. J.</given-names></string-name></person-group> (<year>2015</year>). <article-title>The <italic toggle="yes">Streptomyces leeuwenhoekii</italic> genome: De novo sequencing and assembly in single contigs of the chromosome, circular plasmid pSLE1 and linear plasmid pSLE2</article-title>. <source>BMC Genomics [Electronic Resource]</source>, <volume>16</volume>(<issue>1</issue>), <fpage>485</fpage>.</mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gomez-Escribano</surname>
<given-names>J. P.</given-names>
</string-name>, <string-name><surname>Alt</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bibb</surname><given-names>M. J.</given-names></string-name></person-group> (<year>2016</year>). <article-title>Next generation sequencing of actinobacteria for the discovery of novel natural products</article-title>. <source>Marine Drugs</source>, <volume>14</volume>(<issue>4</issue>), <fpage>78</fpage>.</mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gomez-Escribano</surname>
<given-names>J. P.</given-names>
</string-name>, <string-name><surname>Holmes</surname><given-names>N. A.</given-names></string-name>, <string-name><surname>Schlimpert</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bibb</surname><given-names>M. J.</given-names></string-name>, <string-name><surname>Chandra</surname><given-names>G.</given-names></string-name>, <string-name><surname>Wilkinson</surname><given-names>B.</given-names></string-name>, <string-name><surname>Buttner</surname><given-names>M. J.</given-names></string-name>, <string-name><surname>Bibb</surname><given-names>M. J.</given-names></string-name></person-group> (<year>2021</year>). <article-title><italic toggle="yes">Streptomyces venezuelae</italic> NRRL B-65442: Genome sequence of a model strain used to study morphological differentiation in filamentous actinobacteria</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>48</volume>, <comment>doi: 10.1093/jimb/kuab045</comment>.</mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gordon</surname>
<given-names>D. E.</given-names>
</string-name>, <string-name><surname>Jang</surname><given-names>G. M.</given-names></string-name>, <string-name><surname>Bouhaddou</surname><given-names>M.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Obernier</surname><given-names>K.</given-names></string-name>, <string-name><surname>White</surname><given-names>K. M.</given-names></string-name>, <string-name><surname>O'Meara</surname><given-names>M. J.</given-names></string-name>, <string-name><surname>Rezelj</surname><given-names>V. V.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>J. Z.</given-names></string-name>, <string-name><surname>Swaney</surname><given-names>D. L.</given-names></string-name>, <string-name><surname>Tummino</surname><given-names>T. A.</given-names></string-name>, <string-name><surname>H&#x000fc;ttenhain</surname><given-names>R.</given-names></string-name>, <string-name><surname>Kaake</surname><given-names>R. M.</given-names></string-name>, <string-name><surname>Richards</surname><given-names>A. L.</given-names></string-name>, <string-name><surname>Tutuncuoglu</surname><given-names>B.</given-names></string-name>, <string-name><surname>Foussard</surname><given-names>H.</given-names></string-name>, <string-name><surname>Batra</surname><given-names>J.</given-names></string-name>, <string-name><surname>Haas</surname><given-names>K.</given-names></string-name>, <string-name><surname>Krogan</surname><given-names>N J.</given-names></string-name></person-group> (<year>2020</year>). <article-title>A SARS-CoV-2 protein interaction map reveals targets for drug repurposing</article-title>. <source>Nature</source>, <volume>583</volume>(<issue>7816</issue>), <fpage>459</fpage>&#x02013;<lpage>468</lpage>.<pub-id pub-id-type="pmid">32353859</pub-id></mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gren</surname>
<given-names>T.</given-names>
</string-name>, <string-name><surname>Jergensen</surname><given-names>T. S.</given-names></string-name>, <string-name><surname>Whitford</surname><given-names>C. M.</given-names></string-name>, <string-name><surname>Weber</surname><given-names>T.</given-names></string-name></person-group> (<year>2020</year>). <article-title>High-quality sequencing, assembly, and annotation of the <italic toggle="yes">Streptomyces griseofuscus</italic> DSM 40191 genome</article-title>. <source>Microbiology Resource Announcements</source><volume>9</volume>(<issue>47</issue>), <fpage>e01100</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">33214305</pub-id></mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Guo</surname>
<given-names>C.</given-names>
</string-name>, <string-name><surname>Guo</surname><given-names>W.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>C.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Complete genome sequence of butenyl-spinosyn-producing <italic toggle="yes">Saccharopolyspora</italic> strain ASAGF58</article-title>. <source>Annals of Microbiology</source>, <volume>70</volume>(<issue>1</issue>), <fpage>46</fpage>.</mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hadjithomas</surname>
<given-names>M.</given-names>
</string-name>, <string-name><surname>Chen</surname><given-names>I. A.</given-names></string-name>, <string-name><surname>Chu</surname><given-names>K.</given-names></string-name>, <string-name><surname>Ratner</surname><given-names>A.</given-names></string-name>, <string-name><surname>Palaniappan</surname><given-names>K.</given-names></string-name>, <string-name><surname>Szeto</surname><given-names>E.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Reddy</surname><given-names>T. B.</given-names></string-name>, <string-name><surname>Cimerman&#x0010d;i&#x0010d;</surname><given-names>P.</given-names></string-name>, <string-name><surname>Fischbach</surname><given-names>M. A.</given-names></string-name>, <string-name><surname>Inanova</surname><given-names>N. A.</given-names></string-name>, <string-name><surname>Markowitz</surname><given-names>V. M.</given-names></string-name>, <string-name><surname>Kyrpides</surname><given-names>N. C.</given-names></string-name>, <string-name><surname>Pati</surname><given-names>A.</given-names></string-name></person-group> (<year>2015</year>). <article-title>IMG-ABC: A knowledge base to fuel discovery of biosynthetic gene clusters and novel secondary metabolites</article-title>. <source>mBio</source>, <volume>6</volume>(<issue>4</issue>), <fpage>e00932</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">26173699</pub-id></mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hadjithomas</surname>
<given-names>M.</given-names>
</string-name>, <string-name><surname>Chen</surname><given-names>I. A.</given-names></string-name>, <string-name><surname>Chu</surname><given-names>K.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ratner</surname><given-names>A.</given-names></string-name>, <string-name><surname>Palaniappan</surname><given-names>K.</given-names></string-name>, <string-name><surname>Markowitz</surname><given-names>V.</given-names></string-name>, <string-name><surname>Kyrpides</surname><given-names>N. C.</given-names></string-name>, <string-name><surname>Inanova</surname><given-names>N. N.</given-names></string-name></person-group> (<year>2017</year>). <article-title>IMG-ABC: New features for microbial secondary metabolism analysis and targeted biosynthetic gene cluster discovery in thousands of microbial genomes</article-title>. <source>Nucleic Acids Research</source>, <volume>45</volume>(<issue>D1</issue>), <fpage>D560</fpage>&#x02013;<lpage>D565</lpage>.<pub-id pub-id-type="pmid">27903896</pub-id></mixed-citation></ref><ref id="bib44"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Heinsch</surname>
<given-names>S. C.</given-names>
</string-name>, <string-name><surname>Hsu</surname><given-names>S. Y.</given-names></string-name>, <string-name><surname>Otto-Hansen</surname><given-names>L.</given-names></string-name>, <string-name><surname>Kinkel</surname><given-names>L.</given-names></string-name>, <string-name><surname>Smanski</surname><given-names>M. J.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Complete genome sequences of <italic toggle="yes">Streptomyces</italic> spp. isolated from disease-suppressive soils</article-title>. <source>BMC Genomics [Electronic Resource]</source>, <volume>20</volume>(<issue>1</issue>), <fpage>994</fpage>.</mixed-citation></ref><ref id="bib45"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Iacovelli</surname>
<given-names>R.</given-names>
</string-name>, <string-name><surname>Bovenberg</surname><given-names>R. A. L.</given-names></string-name>, <string-name><surname>Driessen</surname><given-names>A. J. M.</given-names></string-name></person-group> (<year>2021</year>). <article-title>Nonribosomal peptide synthetases and their biotechnological potential in <italic toggle="yes">Penicillium rubens</italic></article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>48</volume>, <comment>doi:10.1093/jimb/kuab035.</comment></mixed-citation></ref><ref id="bib46"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Iftime</surname>
<given-names>D.</given-names>
</string-name>, <string-name><surname>Kulik</surname><given-names>A.</given-names></string-name>, <string-name><surname>H&#x000e4;rtner</surname><given-names>T.</given-names></string-name>, <string-name><surname>Rohrer</surname><given-names>S.</given-names></string-name>, <string-name><surname>Niedermeyer</surname><given-names>T. H.</given-names></string-name>, <string-name><surname>Stegmann</surname><given-names>E.</given-names></string-name>, <string-name><surname>Weber</surname><given-names>T.</given-names></string-name>, <string-name><surname>Wohlleben</surname><given-names>W.</given-names></string-name></person-group> (<year>2016</year>). <article-title>Identification and activation of novel biosynthetic gene clusters by genome mining in the kirromycin producer <italic toggle="yes">Streptomyces collinus</italic> T&#x000fc; 365</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>43</volume>(<issue>2&#x02013;3</issue>), <fpage>277</fpage>&#x02013;<lpage>291</lpage>.<pub-id pub-id-type="pmid">26433383</pub-id></mixed-citation></ref><ref id="bib47"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ikeda</surname>
<given-names>H.</given-names>
</string-name>, <string-name><surname>Ishikawa</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hanamoto</surname><given-names>A.</given-names></string-name>, <string-name><surname>Shinose</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kikuchi</surname><given-names>H.</given-names></string-name>, <string-name><surname>Shiba</surname><given-names>T.</given-names></string-name>, <string-name><surname>Sakaki</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hattori</surname><given-names>M.</given-names></string-name>, <string-name><surname>&#x0014c;mura</surname><given-names>S.</given-names></string-name></person-group> (<year>2003</year>). <article-title>Complete genome sequence and comparative analysis of the industrial microorganism <italic toggle="yes">Streptomyces avermitilis</italic></article-title>. <source>Nature Biotechnology</source>, <volume>21</volume>(<issue>5</issue>), <fpage>526</fpage>&#x02013;<lpage>531</lpage>.</mixed-citation></ref><ref id="bib48"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ikeda</surname>
<given-names>H.</given-names>
</string-name>, <string-name><surname>Shin-ya</surname><given-names>K.</given-names></string-name>, <string-name><surname>&#x0014c;mura</surname><given-names>S.</given-names></string-name></person-group> (<year>2014</year>). <article-title>Genome mining of the <italic toggle="yes">Streptomyces avermitilis</italic> genome and development of genome-minimized hosts for heterologous expression of biosynthetic gene clusters</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>41</volume>(<issue>2</issue>), <fpage>233</fpage>&#x02013;<lpage>250</lpage>.<pub-id pub-id-type="pmid">23990133</pub-id></mixed-citation></ref><ref id="bib49"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kalkreuter</surname>
<given-names>E.</given-names>
</string-name>, <string-name><surname>Pan</surname><given-names>G.</given-names></string-name>, <string-name><surname>Cepeda</surname><given-names>A. J.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>B.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Targeting bacterial genomes for natural product discovery</article-title>. <source>Trends in Pharmacological Sciences</source>, <volume>41</volume>(<issue>1</issue>), <fpage>13</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">31822352</pub-id></mixed-citation></ref><ref id="bib50"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kang</surname>
<given-names>H. S.</given-names>
</string-name>, <string-name><surname>Kim</surname><given-names>E. S.</given-names></string-name></person-group> (<year>2021</year>). <article-title>Recent advances in heterologous expression of natural product biosynthesis gene clusters in <italic toggle="yes">Streptomyces</italic> hosts</article-title>. <source>Current Opinion in Biotechnology</source>, <volume>69</volume>, <fpage>118</fpage>&#x02013;<lpage>127</lpage>.<pub-id pub-id-type="pmid">33445072</pub-id></mixed-citation></ref><ref id="bib51"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Katz</surname>
<given-names>L.</given-names>
</string-name>, <string-name><surname>Baltz</surname><given-names>R. H.</given-names></string-name></person-group> (<year>2016</year>). <article-title>Natural product discovery: Past, present, and future</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>43</volume>(<issue>2-3</issue>), <fpage>155</fpage>&#x02013;<lpage>176</lpage>.<pub-id pub-id-type="pmid">26739136</pub-id></mixed-citation></ref><ref id="bib52"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Katz</surname>
<given-names>L.</given-names>
</string-name>, <string-name><surname>Chen</surname><given-names>Y. Y.</given-names></string-name>, <string-name><surname>Gonzalez</surname><given-names>R.</given-names></string-name>, <string-name><surname>Peterson</surname><given-names>T. C.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>H.</given-names></string-name>, <string-name><surname>Baltz</surname><given-names>R. H.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Synthetic biology advances and applications in the biotechnology industry: A perspective</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>45</volume>(<issue>7</issue>), <fpage>449</fpage>&#x02013;<lpage>461</lpage>.<pub-id pub-id-type="pmid">29915997</pub-id></mixed-citation></ref><ref id="bib53"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kautsar</surname>
<given-names>S. A.</given-names>
</string-name>, <string-name><surname>Blin</surname><given-names>K.</given-names></string-name>, <string-name><surname>Shaw</surname><given-names>S.</given-names></string-name>, <string-name><surname>Navarro-Mu&#x000f1;oz</surname><given-names>J. C.</given-names></string-name>, <string-name><surname>Terlouw</surname><given-names>B. R.</given-names></string-name>, <string-name><surname>van der Hooft</surname><given-names>J. J. J.</given-names></string-name>, <string-name><surname>van Santen</surname><given-names>J. A.</given-names></string-name>, <string-name><surname>Tracanna</surname><given-names>V.</given-names></string-name>, <string-name><surname>Suarez Duran</surname><given-names>H. G.</given-names></string-name>, <string-name><surname>Pascal Andreu</surname><given-names>V.</given-names></string-name>, <string-name><surname>Selem-Mojica</surname><given-names>N.</given-names></string-name>, <string-name><surname>Alanjary</surname><given-names>M.</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>S. L.</given-names></string-name>, <string-name><surname>Lund</surname><given-names>G.</given-names></string-name>, <string-name><surname>Epstein</surname><given-names>S. C.</given-names></string-name>, <string-name><surname>Sisto</surname><given-names>A. C.</given-names></string-name>, <string-name><surname>Charkoudian</surname><given-names>L. K.</given-names></string-name>, <string-name><surname>Collemare</surname><given-names>J.</given-names></string-name>, <string-name><surname>Linington</surname><given-names>R. G.</given-names></string-name>, <string-name><surname>Medema</surname><given-names>M. H.</given-names></string-name></person-group> (<year>2020</year>). <article-title>MIBiG 2.0: A repository for biosynthetic gene clusters of known function</article-title>. <source>Nucleic Acids Research</source>, <volume>48</volume>, <fpage>D454</fpage>&#x02013;<lpage>D458</lpage>.<pub-id pub-id-type="pmid">31612915</pub-id></mixed-citation></ref><ref id="bib54"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kautsar</surname>
<given-names>S. A.</given-names>
</string-name>, <string-name><surname>van der Hooft</surname><given-names>J. J. J.</given-names></string-name>, <string-name><surname>de Ridder</surname><given-names>D.</given-names></string-name>, <string-name><surname>Medema</surname><given-names>M. H.</given-names></string-name></person-group> (<year>2021</year>). <article-title>BiG-SLiCE: A highly scalable tool maps the diversity of 1.2 million biosynthetic gene clusters</article-title>. <source>Gigascience</source>, <volume>10</volume>(<issue>1</issue>), <fpage>giga154</fpage>.</mixed-citation></ref><ref id="bib55"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Klassen</surname>
<given-names>J. I.</given-names>
</string-name>, <string-name><surname>Currie</surname><given-names>C. R.</given-names></string-name></person-group> (<year>2012</year>). <article-title>Gene fragmentation in bacterial draft genomes: Extent, consequences and mitigation</article-title>. <source>BMC Genomics</source>, <volume>13</volume>, <fpage>12</fpage>.<pub-id pub-id-type="pmid">22233519</pub-id></mixed-citation></ref><ref id="bib56"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kono</surname>
<given-names>N.</given-names>
</string-name>, <string-name><surname>Arakawa</surname><given-names>K.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Nanopore sequencing: Review of potential application in functional genomics</article-title>. <source>Development, Growth &#x00026; Differentiation</source>, <volume>61</volume>(<issue>5</issue>), <fpage>316</fpage>&#x02013;<lpage>326</lpage>.</mixed-citation></ref><ref id="bib57"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lampejo</surname>
<given-names>T.</given-names>
</string-name>
</person-group> (<year>2020</year>). <article-title>Dalbavancin and telavancin in the treatment of infective endocarditis: A literature review</article-title>. <source>International Journal of Antimicrobial Agents</source>, <volume>56</volume>(<issue>3</issue>), <fpage>106072</fpage>.<pub-id pub-id-type="pmid">32629114</pub-id></mixed-citation></ref><ref id="bib58"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lee</surname>
<given-names>Y.</given-names>
</string-name>, <string-name><surname>Lee</surname><given-names>N.</given-names></string-name>, <string-name><surname>Hwang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>K.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>W.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>J.</given-names></string-name>, <string-name><surname>Cho</surname><given-names>S.</given-names></string-name>, <string-name><surname>Palsson</surname><given-names>B. O.</given-names></string-name>, <string-name><surname>Cho</surname><given-names>B. K.</given-names></string-name></person-group> (<year>2020</year>). <article-title>System-level understanding of gene expression and regulation for engineering secondary metabolite production in <italic toggle="yes">Streptomyces</italic></article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>47</volume>(<issue>9&#x02013;10</issue>), <fpage>739</fpage>&#x02013;<lpage>752</lpage>.<pub-id pub-id-type="pmid">32778981</pub-id></mixed-citation></ref><ref id="bib59"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Liu</surname>
<given-names>W. T.</given-names>
</string-name>, <string-name><surname>Lamsa</surname><given-names>A.</given-names></string-name>, <string-name><surname>Wong</surname><given-names>W. R.</given-names></string-name>, <string-name><surname>Boudreau</surname><given-names>P. D.</given-names></string-name>, <string-name><surname>Kersten</surname><given-names>R.</given-names></string-name>, <string-name><surname>Peng</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Moree</surname><given-names>W. J.</given-names></string-name>, <string-name><surname>Duggan</surname><given-names>B. M.</given-names></string-name>, <string-name><surname>Moore</surname><given-names>B. S.</given-names></string-name>, <string-name><surname>Gerwick</surname><given-names>W. H.</given-names></string-name>, <string-name><surname>Linington</surname><given-names>R. G.</given-names></string-name>, <string-name><surname>Pogliano</surname><given-names>K.</given-names></string-name>, <string-name><surname>Dorrestein</surname><given-names>P. C.</given-names></string-name></person-group> (<year>2014</year>). <article-title>MS/MS-based networking and peptidogenomics guided genome mining revealed the stenothricin gene cluster in <italic toggle="yes">Streptomyces roseosporus</italic></article-title>. <source>The Journal of Antibiotics</source>, <volume>67</volume>(<issue>1</issue>), <fpage>99</fpage>&#x02013;<lpage>104</lpage>.<pub-id pub-id-type="pmid">24149839</pub-id></mixed-citation></ref><ref id="bib60"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lu</surname>
<given-names>H.</given-names>
</string-name>, <string-name><surname>Giordano</surname><given-names>F.</given-names></string-name>, <string-name><surname>Ning</surname><given-names>Z.</given-names></string-name></person-group> (<year>2016</year>). <article-title>Oxford nanopore MinION sequencing and genome assembly</article-title>. <source>Genomics, Proteomics &#x00026; Bioinformatics</source>, <volume>14</volume>(<issue>5</issue>), <fpage>265</fpage>&#x02013;<lpage>279</lpage>.</mixed-citation></ref><ref id="bib61"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Malabarba</surname>
<given-names>A.</given-names>
</string-name>, <string-name><surname>Nicas</surname><given-names>T. I.</given-names></string-name>, <string-name><surname>Thompson</surname><given-names>R. C.</given-names></string-name></person-group> (<year>1997</year>). <article-title>Structural modifications of glycopeptide antibiotics</article-title>. <source>Medicinal Research Reviews</source>, <volume>17</volume>(<issue>1</issue>), <fpage>69</fpage>&#x02013;<lpage>137</lpage>.<pub-id pub-id-type="pmid">8979249</pub-id></mixed-citation></ref><ref id="bib62"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Medema</surname>
<given-names>M. H.</given-names>
</string-name>, <string-name><surname>Blin</surname><given-names>K.</given-names></string-name>, <string-name><surname>Cimermancic</surname><given-names>P.</given-names></string-name>, <string-name><surname>de Jager</surname><given-names>V.</given-names></string-name>, <string-name><surname>Zakrzewski</surname><given-names>P.</given-names></string-name>, <string-name><surname>Fischbach</surname><given-names>M. A.</given-names></string-name>, <string-name><surname>Weber</surname><given-names>T.</given-names></string-name>, <string-name><surname>Takano</surname><given-names>E.</given-names></string-name>, <string-name><surname>Breitling</surname><given-names>R.</given-names></string-name></person-group> (<year>2011</year>). <article-title>antiSMASH: Rapid identification, annotation, and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences</article-title>. <source>Nucleic Acids Research</source>, <volume>39</volume>(<issue>suppl_2</issue>), <fpage>W339</fpage>&#x02013;<lpage>W346</lpage>.<pub-id pub-id-type="pmid">21672958</pub-id></mixed-citation></ref><ref id="bib63"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Medema</surname>
<given-names>M. H.</given-names>
</string-name>, <string-name><surname>Kottmann</surname><given-names>R.</given-names></string-name>, <string-name><surname>Yilmas</surname><given-names>P.</given-names></string-name>, <string-name><surname>Cummings</surname><given-names>M.</given-names></string-name>, <string-name><surname>Biggins</surname><given-names>J. B.</given-names></string-name>, <string-name><surname>Blin</surname><given-names>K.</given-names></string-name>, <string-name><surname>de Bruijn</surname><given-names>I.</given-names></string-name>, <string-name><surname>Chooi</surname><given-names>Y. H.</given-names></string-name>, <string-name><surname>Claesen</surname><given-names>J.</given-names></string-name>, <string-name><surname>Coates</surname><given-names>R. C.</given-names></string-name>, <string-name><surname>Cruz-Morales</surname><given-names>P.</given-names></string-name>, <string-name><surname>Duddela</surname><given-names>S.</given-names></string-name>, <string-name><surname>D&#x000fc;sterhus</surname><given-names>S.</given-names></string-name>, <string-name><surname>Edwards</surname><given-names>D. J.</given-names></string-name>, <string-name><surname>Fewer</surname><given-names>D. P.</given-names></string-name>, <string-name><surname>Garg</surname><given-names>N.</given-names></string-name>, <string-name><surname>Geiger</surname><given-names>C.</given-names></string-name>, <string-name><surname>Gomez-Escribano</surname><given-names>J. P.</given-names></string-name>, <string-name><surname>Greule</surname><given-names>A.</given-names></string-name>, <string-name><surname>Gl&#x000f6;ckner</surname><given-names>F. O.</given-names></string-name></person-group> (<year>2015</year>). <article-title>Minimum information about a biosynthetic gene cluster</article-title>. <source>Nature Chemical Biology</source>, <volume>11</volume>(<issue>9</issue>), <fpage>625</fpage>&#x02013;<lpage>631</lpage>.<pub-id pub-id-type="pmid">26284661</pub-id></mixed-citation></ref><ref id="bib64"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Merwin</surname>
<given-names>N. J.</given-names>
</string-name>, <string-name><surname>Mousa</surname><given-names>W. K.</given-names></string-name>, <string-name><surname>Dejong</surname><given-names>C. A.</given-names></string-name>, <string-name><surname>Skinnider</surname><given-names>M. A.</given-names></string-name>, <string-name><surname>Cannon</surname><given-names>M. J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>H.</given-names></string-name>, <string-name><surname>Dial</surname><given-names>K.</given-names></string-name>, <string-name><surname>Gunabalasingam</surname><given-names>M.</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>C.</given-names></string-name>, <string-name><surname>Magarvey</surname><given-names>N. A.</given-names></string-name></person-group> (<year>2020</year>). <article-title>DeepRiPP integrates multiomics data to automate discovery of novel ribosomally synthesized natural products</article-title>. <source>Proceedings of the National Academy of Sciences</source>, <volume>117</volume>(<issue>1</issue>), <fpage>371</fpage>&#x02013;<lpage>380</lpage>.</mixed-citation></ref><ref id="bib65"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Miao</surname>
<given-names>V.</given-names>
</string-name>, <string-name><surname>Le Gal</surname><given-names>M. F.</given-names></string-name>, <string-name><surname>Brian</surname><given-names>P.</given-names></string-name>, <string-name><surname>Brost</surname><given-names>R.</given-names></string-name>, <string-name><surname>Penn</surname><given-names>J.</given-names></string-name>, <string-name><surname>Whiting</surname><given-names>A.</given-names></string-name>, <string-name><surname>Martin</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ford</surname><given-names>R.</given-names></string-name>, <string-name><surname>Parr</surname><given-names>I.</given-names></string-name>, <string-name><surname>Bouchard</surname><given-names>M.</given-names></string-name>, <string-name><surname>Silva</surname><given-names>C. J.</given-names></string-name>, <string-name><surname>Wrigley</surname><given-names>S. K.</given-names></string-name>, <string-name><surname>Baltz</surname><given-names>R. H</given-names></string-name></person-group>. (<year>2005</year>). <article-title>Daptomycin biosynthesis in <italic toggle="yes">Streptomyces roseosporus</italic>: Cloning and analysis of the gene cluster and revision of peptide stereochemistry</article-title>. <source>Microbiology (Reading, England)</source>, <volume>151</volume>(<issue>5</issue>), <fpage>1507</fpage>&#x02013;<lpage>1523</lpage>.</mixed-citation></ref><ref id="bib66"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mitousis</surname>
<given-names>L.</given-names>
</string-name>, <string-name><surname>Thoma</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Musiol-Kroll</surname><given-names>E. M</given-names></string-name></person-group>. (<year>2020</year>). <article-title>An update on molecular tools for genetic engineering of actinomycetes - the source of important antibiotics and other valuable compounds</article-title>. <source>Antibiotics</source>, <volume>9</volume>(<issue>8</issue>), <fpage>494</fpage>.</mixed-citation></ref><ref id="bib67"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mungen</surname>
<given-names>D. M.</given-names>
</string-name>, <string-name><surname>Alanjary</surname><given-names>M.</given-names></string-name>, <string-name><surname>Blin</surname><given-names>K.</given-names></string-name>, <string-name><surname>Weber</surname><given-names>T.</given-names></string-name>, <string-name><surname>Medema</surname><given-names>M. H.</given-names></string-name>, <string-name><surname>Ziemert</surname><given-names>N.</given-names></string-name></person-group> (<year>2020</year>). <article-title>ARTS 2.0: Feature updates and expansion of the antibiotic resistance target seeker for comparative genome mining</article-title>. <source>Nucleic Acids Research</source>, <volume>48</volume>(<issue>W1</issue>), <fpage>W546</fpage>&#x02013;<lpage>W552</lpage>.<pub-id pub-id-type="pmid">32427317</pub-id></mixed-citation></ref><ref id="bib68"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Musiol-Kroll</surname>
<given-names>E. M.</given-names>
</string-name>, <string-name><surname>Tocchetti</surname><given-names>A.</given-names></string-name>, <string-name><surname>Sosio</surname><given-names>M.</given-names></string-name>, <string-name><surname>Stegmann</surname><given-names>E.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Challenges and advances in genetic manipulation of filamentous actinomycetes - the remarkable producers of secondary metabolites</article-title>. <source>Natural Product Reports</source>, <volume>36</volume>(<issue>9</issue>), <fpage>1351</fpage>&#x02013;<lpage>1369</lpage>.<pub-id pub-id-type="pmid">31517370</pub-id></mixed-citation></ref><ref id="bib69"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Na&#x000f4;m&#x000e9;</surname>
<given-names>A.</given-names>
</string-name>, <string-name><surname>Maciejewska</surname><given-names>M.</given-names></string-name>, <string-name><surname>Calusinska</surname><given-names>M.</given-names></string-name>, <string-name><surname>Martinet</surname><given-names>L.</given-names></string-name>, <string-name><surname>Anderssen</surname><given-names>S.</given-names></string-name>, <string-name><surname>Adam</surname><given-names>D.</given-names></string-name>, <string-name><surname>Tenconi</surname><given-names>E.</given-names></string-name>, <string-name><surname>Deflandre</surname><given-names>B.</given-names></string-name>, <string-name><surname>Coppieters</surname><given-names>W.</given-names></string-name>, <string-name><surname>Karim</surname><given-names>L.</given-names></string-name>, <string-name><surname>Hanikenne</surname><given-names>M.</given-names></string-name>, <string-name><surname>Baurain</surname><given-names>D.</given-names></string-name>, <string-name><surname>Delfosse</surname><given-names>P.</given-names></string-name>, <string-name><surname>van Wezel</surname><given-names>G. P.</given-names></string-name>, <string-name><surname>Rigali</surname><given-names>S.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Complete genome sequence of <italic toggle="yes">Streptomyces lunaelactis</italic> MM109<sup>T</sup>, isolated from cave moonmilk deposits</article-title>. <source>Genome Announcements</source>, <volume>21</volume>, <fpage>e00435</fpage>&#x02013;<lpage>18</lpage>.</mixed-citation></ref><ref id="bib70"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Navarro-Mu&#x000f1;oz</surname>
<given-names>J. C.</given-names>
</string-name>, <string-name><surname>Selem-Mojica</surname><given-names>N.</given-names></string-name>, <string-name><surname>Mullowney</surname><given-names>M. W.</given-names></string-name>, <string-name><surname>Kautsar</surname><given-names>S. A.</given-names></string-name>, <string-name><surname>Tryon</surname><given-names>J. H.</given-names></string-name>, <string-name><surname>Parkinson</surname><given-names>E. I.</given-names></string-name>, <string-name><surname>De Los Santos</surname><given-names>E. L. C.</given-names></string-name>, <string-name><surname>Yeong</surname><given-names>M.</given-names></string-name>, <string-name><surname>Cruz-Morales</surname><given-names>P.</given-names></string-name>, <string-name><surname>Abubucker</surname><given-names>S.</given-names></string-name>, <string-name><surname>Roeters</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lokhorst</surname><given-names>W.</given-names></string-name>, <string-name><surname>Fernandez-Guerra</surname><given-names>A.</given-names></string-name>, <string-name><surname>Cappelini</surname><given-names>L. T. D.</given-names></string-name>, <string-name><surname>Goering</surname><given-names>A. W.</given-names></string-name>, <string-name><surname>Thomson</surname><given-names>R. J.</given-names></string-name>, <string-name><surname>Metcalf</surname><given-names>W. W.</given-names></string-name>, <string-name><surname>Kelleher</surname><given-names>N. L.</given-names></string-name>, <string-name><surname>Barona-Gomez</surname><given-names>F.</given-names></string-name>, <string-name><surname>Medema</surname><given-names>M. H.</given-names></string-name></person-group> (<year>2020</year>). <article-title>A computational framework to explore large-scale biosynthetic diversity</article-title>. <source>Nature Chemical Biology</source>, <volume>16</volume>(<issue>1</issue>), <fpage>60</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">31768033</pub-id></mixed-citation></ref><ref id="bib71"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Newman</surname>
<given-names>D. J.</given-names>
</string-name>, <string-name><surname>Cragg</surname><given-names>G. M.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019</article-title>. <source>Journal of Natural Products</source>, <volume>83</volume>(<issue>3</issue>), <fpage>770</fpage>&#x02013;<lpage>803</lpage>.<pub-id pub-id-type="pmid">32162523</pub-id></mixed-citation></ref><ref id="bib72"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Nguyen</surname>
<given-names>C. T.</given-names>
</string-name>, <string-name><surname>Dhakal</surname><given-names>D.</given-names></string-name>, <string-name><surname>Phan</surname><given-names>V. T. T.</given-names></string-name>, <string-name><surname>Nguyen</surname><given-names>H. T.</given-names></string-name>, <string-name><surname>Sohng</surname><given-names>J. K.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Recent advances in strategies for activation and discovery/characterization of cryptic biosynthetic gene clusters in <italic toggle="yes">Streptomyces</italic></article-title>. <source>Microorganisms</source>, <volume>8</volume>(<issue>4</issue>), <fpage>616</fpage>.</mixed-citation></ref><ref id="bib73"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Nindita</surname>
<given-names>Y.</given-names>
</string-name>, <string-name><surname>Cao</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Fauzi</surname><given-names>A. A.</given-names></string-name>, <string-name><surname>Teshima</surname><given-names>A.</given-names></string-name>, <string-name><surname>Misaki</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Muslimin</surname><given-names>R.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Shiwa</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yoshikawa</surname><given-names>H.</given-names></string-name>, <string-name><surname>Tagami</surname><given-names>M.</given-names></string-name>, <string-name><surname>Lezhava</surname><given-names>A.</given-names></string-name>, <string-name><surname>Ishikawa</surname><given-names>J.</given-names></string-name>, <string-name><surname>Kuroda</surname><given-names>M.</given-names></string-name>, <string-name><surname>Sekizuka</surname><given-names>T.</given-names></string-name>, <string-name><surname>Inada</surname><given-names>K.</given-names></string-name>, <string-name><surname>Kinashi</surname><given-names>H.</given-names></string-name>, <string-name><surname>Arakawa</surname><given-names>K.</given-names></string-name></person-group> (<year>2019</year>). <article-title>The genome sequence of <italic toggle="yes">Streptomyces rochei</italic> 7434AN4, which carries a linear chromosome and three characteristic linear plasmids</article-title>. <source>Scientific Reports</source>, <volume>9</volume>(<issue>1</issue>), <fpage>10973</fpage>.<pub-id pub-id-type="pmid">31358803</pub-id></mixed-citation></ref><ref id="bib74"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ohnishi</surname>
<given-names>Y.</given-names>
</string-name>, <string-name><surname>Ishikawa</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hara</surname><given-names>H.</given-names></string-name>, <string-name><surname>Suzuki</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ikenoya</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ikeda</surname><given-names>H.</given-names></string-name>, <string-name><surname>Yamashita</surname><given-names>A.</given-names></string-name>, <string-name><surname>Hattori</surname><given-names>M.</given-names></string-name>, <string-name><surname>Horinouchi</surname><given-names>S.</given-names></string-name></person-group> (<year>2008</year>). <article-title>Genome sequence of the streptomycin-producing microorganism <italic toggle="yes">Streptomyces griseus</italic> IFO 13350</article-title>. <source>Journal of Bacteriology</source>, <volume>190</volume>(<issue>11</issue>), <fpage>4050</fpage>&#x02013;<lpage>4060</lpage>.<pub-id pub-id-type="pmid">18375553</pub-id></mixed-citation></ref><ref id="bib75"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Oliynyk</surname>
<given-names>M.</given-names>
</string-name>, <string-name><surname>Samborskyy</surname><given-names>M.</given-names></string-name>, <string-name><surname>Lester</surname><given-names>J. B.</given-names></string-name>, <string-name><surname>Mironenko</surname><given-names>T.</given-names></string-name>, <string-name><surname>Scott</surname><given-names>N.</given-names></string-name>, <string-name><surname>Dickens</surname><given-names>S.</given-names></string-name>, <string-name><surname>Haydock</surname><given-names>S. F.</given-names></string-name>, <string-name><surname>Leadlay</surname><given-names>P. F.</given-names></string-name></person-group> (<year>2007</year>). <article-title>Complete genome sequence of the erythromycin-producing bacterium <italic toggle="yes">Saccharopolyspora erythraea</italic> NRRL23338</article-title>. <source>Nature Biotechnology</source>, <volume>25</volume>(<issue>4</issue>), <fpage>447</fpage>&#x02013;<lpage>453</lpage>.</mixed-citation></ref><ref id="bib76"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Palaniappan</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Chen</surname><given-names>I. M. A.</given-names></string-name>, <string-name><surname>Chu</surname><given-names>K.</given-names></string-name>, <string-name><surname>Ratner</surname><given-names>A.</given-names></string-name>, <string-name><surname>Seshadri</surname><given-names>R.</given-names></string-name>, <string-name><surname>Kyrpides</surname><given-names>N. C.</given-names></string-name>, <string-name><surname>Ivanova</surname><given-names>N. N.</given-names></string-name>, <string-name><surname>Mouncey</surname><given-names>N. J.</given-names></string-name></person-group> (<year>2020</year>). <article-title>IMG-ABC v.5.0: An update to the IMG/atlas of biosynthetic gene clusters knowledgebase</article-title>. <source>Nucleic Acids Research</source>, <volume>48</volume>, <fpage>D422</fpage>&#x02013;<lpage>D430</lpage>.<pub-id pub-id-type="pmid">31665416</pub-id></mixed-citation></ref><ref id="bib77"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Palazzotto</surname>
<given-names>E.</given-names>
</string-name>, <string-name><surname>Tong</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>S. Y.</given-names></string-name>, <string-name><surname>Weber</surname><given-names>T.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Synthetic biology and metabolic engineering of actinomycetes for natural product discovery</article-title>. <source>Biotechnology Advances</source>, <volume>37</volume>(<issue>6</issue>), <fpage>107366</fpage>.<pub-id pub-id-type="pmid">30853630</pub-id></mixed-citation></ref><ref id="bib78"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ren</surname>
<given-names>H.</given-names>
</string-name>, <string-name><surname>Shi</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>H.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Computational tools for discovering and engineering natural product biosynthetic pathways</article-title>. <source>iScience</source>, <volume>23</volume>, <fpage>100795</fpage>.<pub-id pub-id-type="pmid">31926431</pub-id></mixed-citation></ref><ref id="bib79"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Schorn</surname>
<given-names>M. A.</given-names>
</string-name>, <string-name><surname>Verhoeven</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ridder</surname><given-names>L.</given-names></string-name>, <string-name><surname>Huber</surname><given-names>F.</given-names></string-name>, <string-name><surname>Acharya</surname><given-names>D. D.</given-names></string-name>, <string-name><surname>Aksenov</surname><given-names>A. A.</given-names></string-name>, <string-name><surname>Aleti</surname><given-names>G.</given-names></string-name>, <string-name><surname>Moghaddam</surname><given-names>J. A.</given-names></string-name>, <string-name><surname>Aron</surname><given-names>A. T.</given-names></string-name>, <string-name><surname>Aziz</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bauermeister</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bauman</surname><given-names>K. D.</given-names></string-name>, <string-name><surname>Baunach</surname><given-names>M.</given-names></string-name>, <string-name><surname>Beemelmanns</surname><given-names>C.</given-names></string-name>, <string-name><surname>Beman</surname><given-names>J. M.</given-names></string-name>, <string-name><surname>Berlanga-Clavero</surname><given-names>M. V.</given-names></string-name>, <string-name><surname>Blacutt</surname><given-names>A. A.</given-names></string-name>, <string-name><surname>Bode</surname><given-names>H. B.</given-names></string-name>, <string-name><surname>Boullie</surname><given-names>A.</given-names></string-name>, <string-name><surname>van der Hooft</surname><given-names>J. J. J.</given-names></string-name></person-group> (<year>2021</year>). <article-title>A community resource for paired genomic and metabolomic data mining</article-title>. <source>Nature Chemical Biology</source>, <volume>17</volume>(<issue>4</issue>), <fpage>363</fpage>&#x02013;<lpage>368</lpage>.<pub-id pub-id-type="pmid">33589842</pub-id></mixed-citation></ref><ref id="bib80"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sharma</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Ghiffary</surname><given-names>M. R.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>H. U.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>S. Y.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Engineering heterologous hosts for the enhanced production of non-ribosomal peptides</article-title>. <source>Biotechnology and Bioprocess Engineering</source>, <volume>25</volume>(<issue>6</issue>), <fpage>795</fpage>&#x02013;<lpage>809</lpage>.</mixed-citation></ref><ref id="bib81"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Shigdel</surname>
<given-names>U. K.</given-names>
</string-name>, <string-name><surname>Lee</surname><given-names>S. J.</given-names></string-name>, <string-name><surname>Sowa</surname><given-names>M. E.</given-names></string-name>, <string-name><surname>Bowman</surname><given-names>B. R.</given-names></string-name>, <string-name><surname>Robison</surname><given-names>K.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>M.</given-names></string-name>, <string-name><surname>Pua</surname><given-names>K. H.</given-names></string-name>, <string-name><surname>Stiles</surname><given-names>D. T.</given-names></string-name>, <string-name><surname>Blodgett</surname><given-names>J. A. V.</given-names></string-name>, <string-name><surname>Udwary</surname><given-names>D. W.</given-names></string-name>, <string-name><surname>Rajczewski</surname><given-names>A. T.</given-names></string-name>, <string-name><surname>Mann</surname><given-names>A. S.</given-names></string-name>, <string-name><surname>Mostafavi</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hardy</surname><given-names>T.</given-names></string-name>, <string-name><surname>Arya</surname><given-names>S.</given-names></string-name>, <string-name><surname>Weng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Stewart</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kenyon</surname><given-names>K.</given-names></string-name>, <string-name><surname>Morgenstern</surname><given-names>J. P.</given-names></string-name>, <string-name><surname>Verdine</surname><given-names>G. L.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface</article-title>. <source>Proceedings of the National Academy of Sciences</source>, <volume>117</volume>(<issue>29</issue>), <fpage>17195</fpage>&#x02013;<lpage>17203</lpage>.</mixed-citation></ref><ref id="bib82"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Skinnider</surname>
<given-names>M. A.</given-names>
</string-name>, <string-name><surname>Johnston</surname><given-names>C. W.</given-names></string-name>, <string-name><surname>Gunabalasingam</surname><given-names>M.</given-names></string-name>, <string-name><surname>Merwin</surname><given-names>N. J.</given-names></string-name>, <string-name><surname>Kieliszek</surname><given-names>A. M.</given-names></string-name>, <string-name><surname>MacLellan</surname><given-names>R. J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ranieri</surname><given-names>M. R. M.</given-names></string-name>, <string-name><surname>Webster</surname><given-names>A. L. H.</given-names></string-name>, <string-name><surname>Cao</surname><given-names>M. P. T.</given-names></string-name>, <string-name><surname>Pfeifle</surname><given-names>A.</given-names></string-name>, <string-name><surname>Spencer</surname><given-names>N.</given-names></string-name>, <string-name><surname>To</surname><given-names>Q. H.</given-names></string-name>, <string-name><surname>Wallace</surname><given-names>D. P.</given-names></string-name>, <string-name><surname>Dejong</surname><given-names>C. A.</given-names></string-name>, <string-name><surname>Magarvey</surname><given-names>N. A.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Comprehensive prediction of secondary metabolite structure and biological activity from microbial genome sequences</article-title>. <source>Nature Communications</source>, <volume>11</volume>(<issue>1</issue>), <fpage>6058</fpage>.</mixed-citation></ref><ref id="bib83"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Stahlecker</surname>
<given-names>J.</given-names>
</string-name>, <string-name><surname>Mingyar</surname><given-names>E.</given-names></string-name>, <string-name><surname>Ziemert</surname><given-names>N.</given-names></string-name>, <string-name><surname>Mungan</surname><given-names>M. D.</given-names></string-name></person-group> (<year>2021</year>). <article-title>SYN-view: A phylogeny-based synteny exploration tool for the identification of gene clusters linked to antibiotic resistance</article-title>. <source>Molecules (Basel, Switzerland)</source>, <volume>26</volume>(<issue>1</issue>), <fpage>144</fpage>.</mixed-citation></ref><ref id="bib84"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Thaker</surname>
<given-names>M. N.</given-names>
</string-name>, <string-name><surname>Wang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Spanogiannopoulos</surname><given-names>P.</given-names></string-name>, <string-name><surname>Waglechner</surname><given-names>N.</given-names></string-name>, <string-name><surname>King</surname><given-names>A. M.</given-names></string-name>, <string-name><surname>Medina</surname><given-names>R.</given-names></string-name>, <string-name><surname>Wright</surname><given-names>G. D.</given-names></string-name></person-group> (<year>2013</year>). <article-title>Identifying producers of antibacterial compounds by screening for antibiotic resistance</article-title>. <source>Nature Biotechnology</source>, <volume>31</volume>(<issue>10</issue>), <fpage>922</fpage>&#x02013;<lpage>927</lpage>.</mixed-citation></ref><ref id="bib85"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Thaker</surname>
<given-names>M. N.</given-names>
</string-name>, <string-name><surname>Waglechner</surname><given-names>N.</given-names></string-name>, <string-name><surname>Wright</surname><given-names>G. D.</given-names></string-name></person-group> (<year>2014</year>). <article-title>Antibiotic resistance-mediated isolation of scaffold-specific natural product producers</article-title>. <source>Nature Protocols</source>, <volume>9</volume>(<issue>6</issue>), <fpage>1469</fpage>&#x02013;<lpage>1479</lpage>.<pub-id pub-id-type="pmid">24874813</pub-id></mixed-citation></ref><ref id="bib86"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Thibessard</surname>
<given-names>A.</given-names>
</string-name>, <string-name><surname>Haas</surname><given-names>D.</given-names></string-name>, <string-name><surname>Gerbaud</surname><given-names>C.</given-names></string-name>, <string-name><surname>Aigle</surname><given-names>B.</given-names></string-name>, <string-name><surname>Lautru</surname><given-names>S.</given-names></string-name>, <string-name><surname>Pernodet</surname><given-names>J. L.</given-names></string-name>, <string-name><surname>Leblond</surname><given-names>P.</given-names></string-name></person-group> (<year>2015</year>). <article-title>Complete genome sequence of <italic toggle="yes">Streptomyces ambofaciens</italic> ATCC 23877, the spiramycin producer</article-title>. <source>Journal of Biotechnology</source>, <volume>214</volume>, <fpage>117</fpage>&#x02013;<lpage>118</lpage>.<pub-id pub-id-type="pmid">26410452</pub-id></mixed-citation></ref><ref id="bib87"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tian</surname>
<given-names>J.</given-names>
</string-name>, <string-name><surname>Yang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ruan</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wei</surname><given-names>W.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>G.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>W.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>J.</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Ge</surname><given-names>M.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>Y.</given-names></string-name></person-group> (<year>2015</year>). <article-title>The complete genome sequence of a high pristinamycin-producing strain of <italic toggle="yes">Streptomyces pristinaespiralis</italic> HCCB10218</article-title>. <source>Journal of Biotechnology</source>, <volume>214</volume>, <fpage>45</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="pmid">26376468</pub-id></mixed-citation></ref><ref id="bib88"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>van der Heul</surname>
<given-names>H.</given-names>
</string-name>, <string-name><surname>Bilyk</surname><given-names>B. L.</given-names></string-name>, <string-name><surname>McDowall</surname><given-names>K. J</given-names></string-name>, <string-name><surname>Seipke</surname><given-names>R. F.</given-names></string-name>, <string-name><surname>van Wezel</surname><given-names>G. P.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Regulation of antibiotic production in Actinobacteria: New perspectives from the post-genomic era</article-title>. <source>Natural Product Reports</source>, <volume>35</volume>(<issue>6</issue>), <fpage>575</fpage>&#x02013;<lpage>604</lpage>.<pub-id pub-id-type="pmid">29721572</pub-id></mixed-citation></ref><ref id="bib89"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>van Bergeijk</surname>
<given-names>D. A.</given-names>
</string-name>, <string-name><surname>Terlouw</surname><given-names>B. R.</given-names></string-name>, <string-name><surname>Medema</surname><given-names>M. H.</given-names></string-name>, <string-name><surname>van Wezel</surname><given-names>G. P.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Ecology and genomics of Actinobacteria: New concepts for natural product discovery</article-title>. <source>Nature Reviews Microbiology</source>, <volume>18</volume>(<issue>10</issue>), <fpage>546</fpage>&#x02013;<lpage>558</lpage>.<pub-id pub-id-type="pmid">32483324</pub-id></mixed-citation></ref><ref id="bib90"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Waglechner</surname>
<given-names>N.</given-names>
</string-name>, <string-name><surname>McArthur</surname><given-names>A. G.</given-names></string-name>, <string-name><surname>Wright</surname><given-names>G. D.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Phylogenetic reconciliation reveals the natural history of glycopeptide antibiotic biosynthesis and resistance</article-title>. <source>Nature Microbiology</source>, <volume>4</volume>(<issue>11</issue>), <fpage>1862</fpage>&#x02013;<lpage>1871</lpage>.</mixed-citation></ref><ref id="bib91"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Waldron</surname>
<given-names>C.</given-names>
</string-name>, <string-name><surname>Matsushima</surname><given-names>P.</given-names></string-name>, <string-name><surname>Rosteck</surname><given-names>P. R.</given-names></string-name>, <string-name><surname>Broughton</surname><given-names>M. C.</given-names></string-name>, <string-name><surname>Turner</surname><given-names>J.</given-names></string-name>, <string-name><surname>Madduri</surname><given-names>K.</given-names></string-name>, <string-name><surname>Crawford</surname><given-names>K. P.</given-names></string-name>, <string-name><surname>Merlo</surname><given-names>D. J.</given-names></string-name>, <string-name><surname>Baltz</surname><given-names>R. H.</given-names></string-name></person-group> (<year>2001</year>). <article-title>Cloning and analysis of the spinosad biosynthetic gene cluster of <italic toggle="yes">Saccharopolyspora spinosa</italic></article-title>. <source>Chemistry &#x00026; Biology</source>, <volume>8</volume>(<issue>5</issue>), <fpage>487</fpage>&#x02013;<lpage>499</lpage>.<pub-id pub-id-type="pmid">11358695</pub-id></mixed-citation></ref><ref id="bib92"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname>
<given-names>G.</given-names>
</string-name>, <string-name><surname>Zhao</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Ke</surname><given-names>J.</given-names></string-name>, <string-name><surname>Engel</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>Y. M.</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>D.</given-names></string-name>, <string-name><surname>Bingol</surname><given-names>K.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Bowen</surname><given-names>B.</given-names></string-name>, <string-name><surname>Louie</surname><given-names>K.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>B.</given-names></string-name>, <string-name><surname>Evans</surname><given-names>R.</given-names></string-name>, <string-name><surname>Miyamoto</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>K.</given-names></string-name>, <string-name><surname>Kosina</surname><given-names>S.</given-names></string-name>, <string-name><surname>De Raad</surname><given-names>M.</given-names></string-name>, <string-name><surname>Silva</surname><given-names>L.</given-names></string-name>, <string-name><surname>Luhrs</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lubbe</surname><given-names>A.</given-names></string-name>, <string-name><surname>Yoshikuni</surname><given-names>Y.</given-names></string-name></person-group> (<year>2019</year>). <article-title>CRAGE enables rapid activation of biosynthetic gene clusters in undomesticated bacteria</article-title>. <source>Nature Microbiology</source>, <volume>4</volume>(<issue>12</issue>), <fpage>2498</fpage>&#x02013;<lpage>2510</lpage>.</mixed-citation></ref><ref id="bib93"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Weber</surname>
<given-names>T.</given-names>
</string-name>, <string-name><surname>Blin</surname><given-names>K.</given-names></string-name>, <string-name><surname>Duddela</surname><given-names>S.</given-names></string-name>, <string-name><surname>Krug</surname><given-names>D.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>H. U.</given-names></string-name>, <string-name><surname>Bruccoleri</surname><given-names>R.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>S. Y.</given-names></string-name>, <string-name><surname>Fischbach</surname><given-names>M. A.</given-names></string-name>, <string-name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></string-name>, <string-name><surname>Wohlleben</surname><given-names>W.</given-names></string-name>, <string-name><surname>Breitling</surname><given-names>R.</given-names></string-name>, <string-name><surname>Takano</surname><given-names>E.</given-names></string-name>, <string-name><surname>Medema</surname><given-names>M. H.</given-names></string-name></person-group> (<year>2015</year>). <article-title>antiSMASH 3.0 &#x02013; a comprehensive resource for the genome mining of biosynthetic gene clusters</article-title>. <source>Nucleic Acids Research</source>, <volume>43</volume>(<issue>W1</issue>), <fpage>W237</fpage>&#x02013;<lpage>W243</lpage>.<pub-id pub-id-type="pmid">25948579</pub-id></mixed-citation></ref><ref id="bib94"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Whitford</surname>
<given-names>C. M.</given-names>
</string-name>, <string-name><surname>Cruz-Morales</surname><given-names>P.</given-names></string-name>, <string-name><surname>Keasling</surname><given-names>J. D.</given-names></string-name>, <string-name><surname>Weber</surname><given-names>T.</given-names></string-name></person-group> (<year>2021</year>). <article-title>The design-build-test-learn cycle for metabolic engineering of streptomycetes</article-title>. <source>Essays in Biochemistry</source>, <comment>doi: 10.1042/EBC20200132</comment>.</mixed-citation></ref><ref id="bib95"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Xu</surname>
<given-names>M.</given-names>
</string-name>, <string-name><surname>Wright</surname><given-names>G. D.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Heterologous expression-facilitated natural products&#x02019; discovery in actinomycetes</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>46</volume>(<issue>3&#x02013;4</issue>), <fpage>415</fpage>&#x02013;<lpage>431</lpage>.<pub-id pub-id-type="pmid">30446891</pub-id></mixed-citation></ref><ref id="bib96"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yoo</surname>
<given-names>Y. J.</given-names>
</string-name>, <string-name><surname>Kim</surname><given-names>H.</given-names></string-name>, <string-name><surname>Park</surname><given-names>S. R.</given-names></string-name>, <string-name><surname>Yoon</surname><given-names>Y. J.</given-names></string-name></person-group> (<year>2017</year>). <article-title>An overview of rapamycin: From discovery to future perspectives</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>44</volume>(<issue>4&#x02013;5</issue>), <fpage>537</fpage>&#x02013;<lpage>553</lpage>.<pub-id pub-id-type="pmid">27613310</pub-id></mixed-citation></ref><ref id="bib97"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yuzawa</surname>
<given-names>S.</given-names>
</string-name>, <string-name><surname>Backman</surname><given-names>T. W.</given-names></string-name>, <string-name><surname>Keasling</surname><given-names>J. D.</given-names></string-name>, <string-name><surname>Katz</surname><given-names>L.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Synthetic biology of polyketide synthases</article-title>. <source>Journal of Industrial Microbiology and Biotechnology</source>, <volume>45</volume>(<issue>7</issue>), <fpage>621</fpage>&#x02013;<lpage>633</lpage>.<pub-id pub-id-type="pmid">29423743</pub-id></mixed-citation></ref></ref-list></back></article>